Sonus Networks, a leader in SIP communications worldwide, announced today that it has released Lync Enterprise Voice For Dummies, the authoritative educational guide for companies that seek to fully utilize Microsoft Lync deployments. The comprehensive manual is published in partnership with John Wiley and Sons, Inc., publisher of the world’s best-selling For Dummies® reference series.
Microsoft Lync allows users to communicate securely and stay connected with colleagues and customers through applications such as instant messaging (IM), collaboration, conferencing, and voice from virtually anywhere. A January 2013 Webtorials study titled, “Enterprises Place 2013 Unified Communications Bets: How Many Horses in This Race?” discovered that, as a platform for Unified Communications (UC) and enterprise voice, Microsoft Lync has raised considerable awareness and interest from enterprises. Fifty-eight percent of those surveyed have already established plans to deploy Microsoft for IM and presence. The survey also indicated that Microsoft has the inside track to deploy advanced UC functions like web meetings, desktop sharing, and advanced directory services with many buyers.
“As enterprises seek to reduce costs yet add capabilities to their communications environments they are increasingly adopting Microsoft Lync to enable and engage their workforce,” said Wes Durow, vice president, Global Marketing & Go-To-Market Operations, Sonus. “Lync Enterprise Voice For Dummies provides an easy-to-understand guide for businesses to take the maximum advantage of the rich set of UC capabilities that it delivers.”
Lync Enterprise Voice For Dummies examines new features and capabilities enabled by Lync Enterprise Voice and how companies of any size can utilize the unique capabilities of Lync to reduce expenses while still increasing productivity. The book also serves to educate readers about realizing the full benefits of a Lync Enterprise Voice deployment through leveraging session border controllers (SBCs).
“We appreciate Sonus imparting their knowledge of Lync in their new book, Lync Enterprise Voice For Dummies. We look forward to their continued success in sharing the unique interoperability, security and scalability requirements for a successful adoption of Lync Enterprise Voice into new and existing voice and PBX environments,” said Giovanni Mezgec, general manager of Lync Product Marketing, Microsoft.
SBCs serve a critical role in enabling and activating UC platforms, such as Microsoft Lync, across enterprise Session Initiation Protocol (SIP) networks. These powerful network devices protect, secure, simplify, and standardize real-time, SIP-based multimedia communications, including Voice over IP (VoIP) and video. A Microsoft Gold Communications Partner, Sonus helps enterprises optimize Microsoft Lync Enterprise Voice deployments by securing SIP trunking services at the network border and providing a more seamless flow of SIP-based multi-vendor media for UC.
For further information, please visit www.sonus.net
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Friday, June 28, 2013
Chembio Diagnostics, Inc. (CEMI) Announces Membership in Russell Global Index
Point-of-care diagnostics test leader Chembio Diagnostics announced it will soon join the Russell Global Index. According to a preliminary list of additions posted on June 21 at www.russell.com/indexes, the listing will happen on June 28, when Russell Investments reconstitutes its comprehensive set of U.S. and global equity indexes.
Russell Global Index membership remains in place for one year and means automatic inclusion in the appropriate large-cap, small-cap and all-cap indexes, as well as the applicable style, sector, and country indexes. Membership for Russell’s equity indexes is determined chiefly by objective market-capitalization rankings and style attributes. Chembio’s stock will be included in Russell’s Micro-Cap Index.
Chembio continues to build momentum with both sales and product development and is currently in a very strong position. The company’s membership in the Russell Global Index is occurring at a time when Chembio has experienced four consecutive years of profitability and revenue growth. The company now has three FDA-approved rapid HIV tests, including its oral fluid HIV test which is pending CLIA waiver and strong international sales. Chembio is additionally developing a robust POC product pipeline based on the company’s patented DPP technology.
“We are very pleased to join the list of successful companies comprising the Russell Global Index and look forward to the enhanced visibility of our membership,” said Chembio Chairman and CEO Lawrence A. Siebert.
Chembio Diagnostics is engaged in developing, manufacturing, licensing, and marketing proprietary rapid diagnostic tests in the burgeoning $10 billion point-of-care testing market. The company is headquartered in Medford, N.Y., and has approximately 170 employees. Chembio is licensed by the FDA and the USDA and is also certified for the global market under the International Standards Organization (ISO) directive 13.485.
For more information, visit www.chembio.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Russell Global Index membership remains in place for one year and means automatic inclusion in the appropriate large-cap, small-cap and all-cap indexes, as well as the applicable style, sector, and country indexes. Membership for Russell’s equity indexes is determined chiefly by objective market-capitalization rankings and style attributes. Chembio’s stock will be included in Russell’s Micro-Cap Index.
Chembio continues to build momentum with both sales and product development and is currently in a very strong position. The company’s membership in the Russell Global Index is occurring at a time when Chembio has experienced four consecutive years of profitability and revenue growth. The company now has three FDA-approved rapid HIV tests, including its oral fluid HIV test which is pending CLIA waiver and strong international sales. Chembio is additionally developing a robust POC product pipeline based on the company’s patented DPP technology.
“We are very pleased to join the list of successful companies comprising the Russell Global Index and look forward to the enhanced visibility of our membership,” said Chembio Chairman and CEO Lawrence A. Siebert.
Chembio Diagnostics is engaged in developing, manufacturing, licensing, and marketing proprietary rapid diagnostic tests in the burgeoning $10 billion point-of-care testing market. The company is headquartered in Medford, N.Y., and has approximately 170 employees. Chembio is licensed by the FDA and the USDA and is also certified for the global market under the International Standards Organization (ISO) directive 13.485.
For more information, visit www.chembio.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
VistaGen Therapeutics, Inc. (VSTA) Issues Update on $36M Strategic Financing Agreement with Autlion
VistaGen Therapeutics, a biotech company applying pluripotent stem cell technology for drug rescue, predictive toxicology, and drug metabolism assays, today provided an update on the status of its strategic financing agreement with Autilion AG.
VistaGen in April signed an initial agreement with Autilion, a Bergamo Acquisition Corp. subsidiary, in which Autilion committed to invest $36 million in VistaGen in consideration for 72 million shares of restricted VistaGen common stock, at a price of $0.50 per share, in a series of closings ending on or before September 30, 2013.
Under the terms of the parties’ amended agreement, the parties today report that they have completed a first closing and scheduled additional closings to occur in July, August, and September 2013. As previously announced, the self-placed strategic financing does not include warrants or investment banking fees.
“I met with Autilion’s team earlier this week, and we have been working closely with them since signing our agreement in April,” Shawn K. Singh, VistaGen’s CEO, stated in the press release. “We are confident and excited about completing this transformative financing. Building on the positive developments in our labs presented during the Annual Meetings of the Society of Toxicology and International Society of Stem Cell Research in March and this month, respectively, we look forward to accelerating our lead programs towards valuable outcomes for our shareholders.”
VistaGen’s drug rescue activities integrate the company’s human pluripotent stem cell technology platform, Human Clinical Trials in a Test Tube™, with modern medicinal chemistry to create novel, safer chemical variants (Drug Rescue Variants) of once-promising small molecule drug candidates.
For more information, visit www.vistagen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
VistaGen in April signed an initial agreement with Autilion, a Bergamo Acquisition Corp. subsidiary, in which Autilion committed to invest $36 million in VistaGen in consideration for 72 million shares of restricted VistaGen common stock, at a price of $0.50 per share, in a series of closings ending on or before September 30, 2013.
Under the terms of the parties’ amended agreement, the parties today report that they have completed a first closing and scheduled additional closings to occur in July, August, and September 2013. As previously announced, the self-placed strategic financing does not include warrants or investment banking fees.
“I met with Autilion’s team earlier this week, and we have been working closely with them since signing our agreement in April,” Shawn K. Singh, VistaGen’s CEO, stated in the press release. “We are confident and excited about completing this transformative financing. Building on the positive developments in our labs presented during the Annual Meetings of the Society of Toxicology and International Society of Stem Cell Research in March and this month, respectively, we look forward to accelerating our lead programs towards valuable outcomes for our shareholders.”
VistaGen’s drug rescue activities integrate the company’s human pluripotent stem cell technology platform, Human Clinical Trials in a Test Tube™, with modern medicinal chemistry to create novel, safer chemical variants (Drug Rescue Variants) of once-promising small molecule drug candidates.
For more information, visit www.vistagen.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Thursday, June 27, 2013
Billabong US Partners with Planet Payment, Inc. (PLPM) Pay in Your Currency Solution
Leading international multi-currency payment processor Planet Payment announced today that Vantiv, a leading provider of payment processing services and other similar technology solutions for both merchants and financial institutions alike, launched Planet Payment’s Pay in Your Currency. The service is currently being implemented at 85 Billabong storefronts across the US. Australia-based Billabong is a leading multi-brand, distribution, and international manufacturing organization focused specifically on surf wear and sports apparel for consumers throughout the world. Billabong currently manufactures and distributes goods to over 100 countries, representing some of the biggest names in the athletic industry.
“As a global brand with a large international following, Billabong’s customers come and shop in our U.S. stores from across the globe,” commented retail IT manager at Billabong USA, Roger Moreno. “We strive to provide our valued international customers with a better, more comfortable shopping experience and we believe that the Pay in Your Currency solution – provided through Vantiv – helps us achieve this goal by allowing them to pay in their home currency.”
The Pay in Your Currency service allows international travelers and shoppers to pay for purchases using a Visa® or MasterCard® alongside the great option to pay in their own home currency at the point of sale, rather than relying on their financial or banking institution to perform the conversion, often times for a prominent fee. The service insures better clarity, ultimately identifying international purchases and then allowing for the option to pay in a choice countries currency. Planet Payment currently provides services in more than 20 countries and territories across the Asia Pacific region, North America, the Middle East, Africa, and Europe.
“Vantiv is pleased to launch the Pay in Your Currency solution at Billabong,” said Donald Boeding who currently sits as president of merchant services at Vantiv. “It is our top priority to provide our merchant clients with innovative, value-added payment solutions that allow them to do more than simply process payments. Our relationship with Planet Payment is a prime example of how our partner relationships enable merchants like Billabong to increase sales and provide new payments functionality.”
“The Pay in Your Currency solution eliminates the guess work associated with international transactions,” commented chief executive officer of Planet Payment, Philip D. Beck, “Savvy businesses, like Billabong, are looking for new ways to increase sales from their international clientele, improve customer service and increase profitability. Offering Pay in Your Currency allows businesses to accomplish these objectives.”
For more information, please visit www.vantiv.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
“As a global brand with a large international following, Billabong’s customers come and shop in our U.S. stores from across the globe,” commented retail IT manager at Billabong USA, Roger Moreno. “We strive to provide our valued international customers with a better, more comfortable shopping experience and we believe that the Pay in Your Currency solution – provided through Vantiv – helps us achieve this goal by allowing them to pay in their home currency.”
The Pay in Your Currency service allows international travelers and shoppers to pay for purchases using a Visa® or MasterCard® alongside the great option to pay in their own home currency at the point of sale, rather than relying on their financial or banking institution to perform the conversion, often times for a prominent fee. The service insures better clarity, ultimately identifying international purchases and then allowing for the option to pay in a choice countries currency. Planet Payment currently provides services in more than 20 countries and territories across the Asia Pacific region, North America, the Middle East, Africa, and Europe.
“Vantiv is pleased to launch the Pay in Your Currency solution at Billabong,” said Donald Boeding who currently sits as president of merchant services at Vantiv. “It is our top priority to provide our merchant clients with innovative, value-added payment solutions that allow them to do more than simply process payments. Our relationship with Planet Payment is a prime example of how our partner relationships enable merchants like Billabong to increase sales and provide new payments functionality.”
“The Pay in Your Currency solution eliminates the guess work associated with international transactions,” commented chief executive officer of Planet Payment, Philip D. Beck, “Savvy businesses, like Billabong, are looking for new ways to increase sales from their international clientele, improve customer service and increase profitability. Offering Pay in Your Currency allows businesses to accomplish these objectives.”
For more information, please visit www.vantiv.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Eric Wolf Joins Dynamics Research Corp. (DRCO)
Leading technology and management company Dynamics Research announced that Eric Wolf has joined the company as vice president and general manager of its Homeland Security Solutions Division.
DRC supports every major component of the Department of Homeland Security, from transportation security to law enforcement and intelligence activities. Homeland security is one of DRC’s key growth markets, and currently represents 13 percent of the company’s annual revenue.
Mr. Wolf will lead the division in its support of homeland security customers in IT policy and planning, enterprise technology architecture, cyber security, information security performance management, and systems engineering.
“Eric is truly a visionary in the government technology marketplace,” said Jim Regan, DRC chairman and CEO. “His executive management experience with leading companies will be a tremendous asset to DRC and our homeland security clients.”
Mr. Wolf’s expertise is perfectly suited for this position, as his resume includes over 25 years of experience in management, technical, and research and development roles within organizations that support federal, civilian, defense, state, and local agencies.
“Being at DRC will allow me to tackle some of the most pressing priorities in homeland security and contribute to programs and operations in areas such as cyber security and border protection that are vital to our nation’s defense,” Mr. Wolf remarked.
Prior to joining DRC, Mr. Wolf spent 11 years with L-3 Communications in a number of leadership positions, including serving as the vice president of an IT services line of business. While in this role, he grew annual sales to almost $70 million dollars.
Mr. Wolf began his career as a software engineer at E-Systems, where he successfully developed an innovative product and associated line of business for three-dimensional visualization and de-confliction of military battle space. He holds a bachelor’s degree from George Washington University School of Engineering and Applied Science, and also completed The General Managers Program at Harvard Business School.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
DRC supports every major component of the Department of Homeland Security, from transportation security to law enforcement and intelligence activities. Homeland security is one of DRC’s key growth markets, and currently represents 13 percent of the company’s annual revenue.
Mr. Wolf will lead the division in its support of homeland security customers in IT policy and planning, enterprise technology architecture, cyber security, information security performance management, and systems engineering.
“Eric is truly a visionary in the government technology marketplace,” said Jim Regan, DRC chairman and CEO. “His executive management experience with leading companies will be a tremendous asset to DRC and our homeland security clients.”
Mr. Wolf’s expertise is perfectly suited for this position, as his resume includes over 25 years of experience in management, technical, and research and development roles within organizations that support federal, civilian, defense, state, and local agencies.
“Being at DRC will allow me to tackle some of the most pressing priorities in homeland security and contribute to programs and operations in areas such as cyber security and border protection that are vital to our nation’s defense,” Mr. Wolf remarked.
Prior to joining DRC, Mr. Wolf spent 11 years with L-3 Communications in a number of leadership positions, including serving as the vice president of an IT services line of business. While in this role, he grew annual sales to almost $70 million dollars.
Mr. Wolf began his career as a software engineer at E-Systems, where he successfully developed an innovative product and associated line of business for three-dimensional visualization and de-confliction of military battle space. He holds a bachelor’s degree from George Washington University School of Engineering and Applied Science, and also completed The General Managers Program at Harvard Business School.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
PITOOEY!, Inc. (PTOO): Shareholder Update Reflects Competitive, Firm Foothold in Burgeoning Digital Advertising Space
PITOOEY!, a digital marketing agency operating through three subsidiaries, is positioned to capitalize on the digital advertising industry, in which eMarkter estimates that $100 billion was spent in 2012 and is expected to grow by more than 15 percent in 2013.
The company’s flagship product, the PITOOEY!™ mobile application, is offered through the PITOOEY! Mobile, Inc. subsidiary. The app is a mobile ad network in which businesses send highly targeted messages and/or deals to subscribing consumers. The beta version is currently available on the iTunes® App Store(sm). This enables businesses to deliver to interested consumers only the message content that they have expressed a desire to receive and ensures that consumers only receive messages from businesses of their choice.
PTOO is currently working on the next iteration of the PITOOEY! App and expects to release Version 2 in its third quarter 2013. The PITOOEY! App is being developed by PTOO subsidiary, Rockstar Digital, a boutique digital agency that creates, markets, and manages digital content such as mobile apps, Web sites, and social media and digital campaigns.
Wholly owned subsidiary Choice One Mobile (C1M) is a digital social media and marketing company that offers customizable design strategies based on each client’s unique and individual digital marketing needs. Formed in December 2012, C1M generated first-quarter revenues of $52,000, and PTO expects that C1M’s net revenues for the second quarter of 2013 to exceed the previous quarter.
PTOO recently launched the C1M Affiliate Marketing Program, which allows credit card processing companies to provide their agents an additional revenue stream by selling C1M’s mobile and social media services to their existing merchant clientele. This is expected to position C1M with greater market penetration and lower overhead and customer acquisition costs.
The global digital marketing industry is forecast to top $160 billion by 2016, according to eMarketer. Of that amount, approximately $24 billion will be dedicated specifically to mobile advertising by 2016. Because PTOO services encompass both social media and mobile advertising services, the company believes it is uniquely positioned to capture a niche in this large and rapidly growing industry.
To assist in executing this expectation, PTOO recently entered into an agreement with financial advisory firm TopHat Capital, LLC, which will help PTOO evaluate capital structures and raise awareness of its presence to potential capital sources from accredited investors.
In the meantime, PTOO is moving forward with a concentrated focus on the launch of Version 2 of the PITOOEY! App and plans on executing strategic marketing programs to promote the app and obtain greater market share for the C1M Affiliate Program.
There are several key factors that PTOO believes put it ahead of competitors in the digital marketing space, including:
• An integrated, scalable, and relatively easy to implement platform, which can expand the reach of their future campaigns;
• Solutions providing high quality functionality that meets their immediate marketing and advertising needs;
• Sophisticated analytics and reporting; and
• High levels of quality service and support.
For more information, visit www.PitooeyInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
The company’s flagship product, the PITOOEY!™ mobile application, is offered through the PITOOEY! Mobile, Inc. subsidiary. The app is a mobile ad network in which businesses send highly targeted messages and/or deals to subscribing consumers. The beta version is currently available on the iTunes® App Store(sm). This enables businesses to deliver to interested consumers only the message content that they have expressed a desire to receive and ensures that consumers only receive messages from businesses of their choice.
PTOO is currently working on the next iteration of the PITOOEY! App and expects to release Version 2 in its third quarter 2013. The PITOOEY! App is being developed by PTOO subsidiary, Rockstar Digital, a boutique digital agency that creates, markets, and manages digital content such as mobile apps, Web sites, and social media and digital campaigns.
Wholly owned subsidiary Choice One Mobile (C1M) is a digital social media and marketing company that offers customizable design strategies based on each client’s unique and individual digital marketing needs. Formed in December 2012, C1M generated first-quarter revenues of $52,000, and PTO expects that C1M’s net revenues for the second quarter of 2013 to exceed the previous quarter.
PTOO recently launched the C1M Affiliate Marketing Program, which allows credit card processing companies to provide their agents an additional revenue stream by selling C1M’s mobile and social media services to their existing merchant clientele. This is expected to position C1M with greater market penetration and lower overhead and customer acquisition costs.
The global digital marketing industry is forecast to top $160 billion by 2016, according to eMarketer. Of that amount, approximately $24 billion will be dedicated specifically to mobile advertising by 2016. Because PTOO services encompass both social media and mobile advertising services, the company believes it is uniquely positioned to capture a niche in this large and rapidly growing industry.
To assist in executing this expectation, PTOO recently entered into an agreement with financial advisory firm TopHat Capital, LLC, which will help PTOO evaluate capital structures and raise awareness of its presence to potential capital sources from accredited investors.
In the meantime, PTOO is moving forward with a concentrated focus on the launch of Version 2 of the PITOOEY! App and plans on executing strategic marketing programs to promote the app and obtain greater market share for the C1M Affiliate Program.
There are several key factors that PTOO believes put it ahead of competitors in the digital marketing space, including:
• An integrated, scalable, and relatively easy to implement platform, which can expand the reach of their future campaigns;
• Solutions providing high quality functionality that meets their immediate marketing and advertising needs;
• Sophisticated analytics and reporting; and
• High levels of quality service and support.
For more information, visit www.PitooeyInc.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Mandalay Digital Group, Inc. (MNDL) Hits the Virtual Road to Host Conference Call Discussing Company Hot Topics
Mandalay Digital today is hosting a virtual roadshow conference call with media, investors, and analysts to highlight the mobile services platform company’s business model, recent developments, and outlook for fiscal 2014. Mandalay CEO Peter Adderton will be joined by Bill Stone, CEO of Digital Turbine, Mandalay’s key technology platform, to host a formal Q&A session.
Los Angeles-based Mandalay offers a scalable, end-to-end mobile content and distribution platform that works with mobile and third-party publishers to ultimately provide efficient distribution of mobile entertainment. The company has established a global reach with offices in Australia, Germany, and Israel.
To participate in the Web cast:
U.S./Toll free: 877-941-2068
International: 480-629-9712
Conference ID: 4625094
Webcast link: http://public.viavid.com/index.php?id=105034
A recording of the call can be accessed by dialing 877-870-5176 or 858-384-5517. Use the replay PIN number 4625094 to initiate playback.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Los Angeles-based Mandalay offers a scalable, end-to-end mobile content and distribution platform that works with mobile and third-party publishers to ultimately provide efficient distribution of mobile entertainment. The company has established a global reach with offices in Australia, Germany, and Israel.
To participate in the Web cast:
U.S./Toll free: 877-941-2068
International: 480-629-9712
Conference ID: 4625094
Webcast link: http://public.viavid.com/index.php?id=105034
A recording of the call can be accessed by dialing 877-870-5176 or 858-384-5517. Use the replay PIN number 4625094 to initiate playback.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Digital Cinema Destinations Corp. (DCIN) Management Guides Acquisition Strategy toward Expansion
Digital Cinema Destinations is a rapidly growing U.S. motion picture exhibitor featuring major motion pictures, coverage of live sports events, concerts, conferences, operas, ballet, Broadway plays, independent films, and more.
Founded in 2010, the company currently operates 18 cinemas and 178 screens scattered throughout Arizona, California, New Jersey, Pennsylvania, and Ohio.
Digiplex is managed by a three-person leadership team and supported by four independent board members.
Company CEO Bud Mayo is an industry veteran with more than 20 years of experience. He is also the founder and former leader of Cinedigm Digital Corp. (CIDM). Digiplex CFO Brian Pflug is the former controller at Clearview Cinemas and is former SVP of accounting and finance at Cinedigm Digital. Jeff Butkovsky serves the company as chief technology officer. Butkovsky is the former SVP and chief technology officer of Cinedigm Digital.
Digiplex has established a proven business model as it reaches to execute its ongoing acquisition strategy, which currently targets about 100 locations throughout the United States.
The company’s strategy is to acquire cash flow positive theaters in top locations, convert all analog screens to digital, and to transform these theaters into entertainment destinations by offering innovative programming and marketing strategies.
For more information, visit www.digiplexdest.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Founded in 2010, the company currently operates 18 cinemas and 178 screens scattered throughout Arizona, California, New Jersey, Pennsylvania, and Ohio.
Digiplex is managed by a three-person leadership team and supported by four independent board members.
Company CEO Bud Mayo is an industry veteran with more than 20 years of experience. He is also the founder and former leader of Cinedigm Digital Corp. (CIDM). Digiplex CFO Brian Pflug is the former controller at Clearview Cinemas and is former SVP of accounting and finance at Cinedigm Digital. Jeff Butkovsky serves the company as chief technology officer. Butkovsky is the former SVP and chief technology officer of Cinedigm Digital.
Digiplex has established a proven business model as it reaches to execute its ongoing acquisition strategy, which currently targets about 100 locations throughout the United States.
The company’s strategy is to acquire cash flow positive theaters in top locations, convert all analog screens to digital, and to transform these theaters into entertainment destinations by offering innovative programming and marketing strategies.
For more information, visit www.digiplexdest.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Wednesday, June 26, 2013
LabStyle Innovations Corp. (DRIO) Announces Appointment of Renowned Diabetes Expert to Board of Directors
LabStyle Innovations, the developer of the Dario™ smartphone-based diabetes medical device and data management system, announced that Prof. Itamar Raz, M.D., has been appointed to the Board of Directors, and he will serve on the Compensation Committee of the board. The company confirmed that Mr. Raz will continue to lead LabStyle’s Scientific Advisory Committee. The announcement was made from the American Diabetes Association’s 73rd Scientific Sessions, which is underway at the McCormick Place Convention Center in Chicago.
A world-renowned leader in diabetes treatment and research, Dr. Raz is an advisor to leading companies in the field. Currently serving as a professor of internal medicine at Hadassah University Medical Center in Israel, Dr. Raz is also the head of the Israel National Council of Diabetes of the Israel Ministry of Health, which is responsible for formulating national policies, the President of D-Cure, a diabetes not-for-profit organization, and the head of the Israel Diabetes Research Group. Dr. Raz also serves as a member of Advisory Boards of diabetes leaders Novo Nordisk (NVO), AstraZeneca/Bristol-Myers Squibb (NYSE: AZN / NYSE: BMY), Sanofi (SNY), Merck Sharp & Dohme (NYSE: MRK), and Eli Lilly (LLY).
“Dr. Raz strengthens our Board of Directors with his deep expertise in diabetes as a researcher, professor and tireless advocate for better treatment,” stated Dr. Oren Fuerst, LabStyle’s Chairman and Chief Executive Officer. “He is highly visible and well regarded in the diabetes community worldwide, and will be a valuable asset to our company as we seek to bring the many benefits of Dario to diabetics around the world.”
Commenting on his appointment, Dr. Raz added, “New tools and treatments for diabetics will help to contain the devastating impact of the growing diabetes epidemic. Information is the first step in improving outcomes. Dario is an innovative device and data-management system that I believe will catalyze more frequent testing due to its all-in-one design, while its many features, including the ability to share data in real-time with caregivers, will enable personalized care. In addition web-based social interactions between patients catalyzed by Dario create the potential for significant benefits through greater patient compliance.”
Dr. Raz is currently leading several international and clinical studies involving prevention and treatment of type 1 diabetes at Hadassah Hebrew University Hospital. With over 190 publications to his credit, Dr. Raz has published extensively on diabetes and also serves as a member of several medical editorial boards. Dr. Raz has organized several international meetings focused on diabetes, the largest being CODHy – Controversies in Obesity, Diabetes, and Hypertension.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
A world-renowned leader in diabetes treatment and research, Dr. Raz is an advisor to leading companies in the field. Currently serving as a professor of internal medicine at Hadassah University Medical Center in Israel, Dr. Raz is also the head of the Israel National Council of Diabetes of the Israel Ministry of Health, which is responsible for formulating national policies, the President of D-Cure, a diabetes not-for-profit organization, and the head of the Israel Diabetes Research Group. Dr. Raz also serves as a member of Advisory Boards of diabetes leaders Novo Nordisk (NVO), AstraZeneca/Bristol-Myers Squibb (NYSE: AZN / NYSE: BMY), Sanofi (SNY), Merck Sharp & Dohme (NYSE: MRK), and Eli Lilly (LLY).
“Dr. Raz strengthens our Board of Directors with his deep expertise in diabetes as a researcher, professor and tireless advocate for better treatment,” stated Dr. Oren Fuerst, LabStyle’s Chairman and Chief Executive Officer. “He is highly visible and well regarded in the diabetes community worldwide, and will be a valuable asset to our company as we seek to bring the many benefits of Dario to diabetics around the world.”
Commenting on his appointment, Dr. Raz added, “New tools and treatments for diabetics will help to contain the devastating impact of the growing diabetes epidemic. Information is the first step in improving outcomes. Dario is an innovative device and data-management system that I believe will catalyze more frequent testing due to its all-in-one design, while its many features, including the ability to share data in real-time with caregivers, will enable personalized care. In addition web-based social interactions between patients catalyzed by Dario create the potential for significant benefits through greater patient compliance.”
Dr. Raz is currently leading several international and clinical studies involving prevention and treatment of type 1 diabetes at Hadassah Hebrew University Hospital. With over 190 publications to his credit, Dr. Raz has published extensively on diabetes and also serves as a member of several medical editorial boards. Dr. Raz has organized several international meetings focused on diabetes, the largest being CODHy – Controversies in Obesity, Diabetes, and Hypertension.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Alexza Pharmaceuticals, Inc. (ALXA) Announces Dr. Michael S. Holfinger as Vice President of Manufacturing & Global Supply Chain Management
Alexza Pharmaceuticals announced that Michael S. Holfinger, PhD, has been recruited to the position of Vice President of Manufacturing & Global Supply Chain Management.
With more than two decades of experience in process development and global manufacturing for a number of commercial products at multinational pharmaceutical, Dr. Holfinger has accumulated extensive experience in pharmaceutical companies. In this role Dr. Holfinger will manage Alexza’s manufacturing activities for ADASUVE® (Staccato® loxapine) as well as for other product candidates in development. Dr. Holfinger will be reporting to Michael Simms, who currently sits as Senior Vice President of Operations and Manufacturing.
“With the recent approval of ADASUVE in the U.S. and EU, and commercial partnerships in place with Teva and Grupo Ferrer, it is an exciting time to join Alexza,” commented Dr. Holfinger. “I look forward to working with Alexza’s talented team in optimizing the manufacturing capabilities and supply management systems to ensure the continuous availability of ADASUVE to clinicians and patients.”
“We are very pleased to welcome Mike to our management team,” stated Thomas B. King, President and CEO. “Mike brings a large set of relevant experiences and skills in the areas of commercial manufacturing and global supply chain management. We look forward to his contributions as we escalate the production of ADASUVE for the upcoming launches of our first product.”
From June 2006 to June 2013, Dr. Holfinger has held a variety of positions at Affymax, Inc., most recently acting as Vice President of Manufacturing & CMC Development. From April 2003 to June 2006, Dr. Holfinger sat as Senior Manager of Global Manufacturing Services at Pfizer, Inc. Prior to Pfizer, from March 1992 until its acquisition by Pfizer, Inc. in April 2003, Dr. Holfinger has held multiple positions at Pharmacia Corporation, formerly The Upjohn Company, including his most recent position of Senior Project Manager of Global Supply. Dr. Holfinger earned his PhD in chemical engineering from the University of Wisconsin, Madison as well as received dual BS degrees in applied science and in chemistry at Miami University.
For more information about Alexza, please visit www.adasuve.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
With more than two decades of experience in process development and global manufacturing for a number of commercial products at multinational pharmaceutical, Dr. Holfinger has accumulated extensive experience in pharmaceutical companies. In this role Dr. Holfinger will manage Alexza’s manufacturing activities for ADASUVE® (Staccato® loxapine) as well as for other product candidates in development. Dr. Holfinger will be reporting to Michael Simms, who currently sits as Senior Vice President of Operations and Manufacturing.
“With the recent approval of ADASUVE in the U.S. and EU, and commercial partnerships in place with Teva and Grupo Ferrer, it is an exciting time to join Alexza,” commented Dr. Holfinger. “I look forward to working with Alexza’s talented team in optimizing the manufacturing capabilities and supply management systems to ensure the continuous availability of ADASUVE to clinicians and patients.”
“We are very pleased to welcome Mike to our management team,” stated Thomas B. King, President and CEO. “Mike brings a large set of relevant experiences and skills in the areas of commercial manufacturing and global supply chain management. We look forward to his contributions as we escalate the production of ADASUVE for the upcoming launches of our first product.”
From June 2006 to June 2013, Dr. Holfinger has held a variety of positions at Affymax, Inc., most recently acting as Vice President of Manufacturing & CMC Development. From April 2003 to June 2006, Dr. Holfinger sat as Senior Manager of Global Manufacturing Services at Pfizer, Inc. Prior to Pfizer, from March 1992 until its acquisition by Pfizer, Inc. in April 2003, Dr. Holfinger has held multiple positions at Pharmacia Corporation, formerly The Upjohn Company, including his most recent position of Senior Project Manager of Global Supply. Dr. Holfinger earned his PhD in chemical engineering from the University of Wisconsin, Madison as well as received dual BS degrees in applied science and in chemistry at Miami University.
For more information about Alexza, please visit www.adasuve.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Mitel (MITL) Partners with Vidyo to Bring Telepresence to the Cloud
Mitel®, a global provider of unified communications and collaboration (UCC) software, solutions, and services that enable organizations to conduct business anywhere, and Vidyo have formed a partnership to deliver a single, comprehensive offering that will incorporate Vidyo’s HD video and telepresence solutions into all of Mitel’s UCC products, as well as integration into MiCloud as a Service in the U.S. This reseller and distribution agreement stipulates that Mitel’s global channel partners will have the ability to provide the UCC end-to-end video conferencing solution, also available as a cloud offering. Customers who have already seized the opportunity are seeing substantial cost savings in addition to a boost in productivity.
“We explored options and with Mitel and Vidyo we can achieve the same result for a fraction of the cost. We’re pushing the boundaries of how we can collaborate with a solution that is secure, self-contained and simple to use. The power of that is we can now have staff and clinicians working properly and effectively at home with high resolution, high-quality images,” said Mike Press, Assistant Director of NHIS at Nottinghamshire Health Informatics Service, a shared information and communications technology service provider in the U.K. supporting the technology needs of a range of customers within the National Health Service (NHS).
This innovative joint solution was designed with a focus on ease-of-use and neatly incorporates video as integral portion of Mitel’s voice and collaboration platform. The video-enabled solution is incredibly flexible because the Vidyo technology and Mitel’s UCC are software-based. This fact also makes the solution perfectly suited for public, private, and hybrid cloud deployments.
“After shipping two generations of scalable and cost effective systems that can scale personal telepresence from legacy room system to mobile and desktop, we are focused on making our best-in-class conferencing infrastructure even more accessible to end users,” said Ofer Shapiro, co-founder and CEO of Vidyo. “We are excited by the collaboration with Mitel that will put our immersive conferencing infrastructure a click away from any Mitel UC users. The partnership is a perfect example of how the VidyoWorks platform can be used to enhance business workflow.”
The ability to empower collaboration, both internally among employees and externally with partners, suppliers, and customers, is one of the primary needs in today’s business environment. The Mitel/Vidyo integrated solution will enable video conferencing across an organization and beyond. It brings UC driven business-class video conferencing to major mobile devices, including smartphones, tablets and laptops, as well as desktop and in-room systems and across all networks to fully support BYOD initiatives.
“Video is a game changer for business communications, delivering an intuitive real-time experience that boosts productivity and builds closer team cohesion. Getting video to actually work within the organization and especially across other media, on the other hand, has been a challenge,” said Ron Wellard, EVP and GM, Mitel Communications. “Our integrated Vidyo solution, closely tying video into our MiCollab and MiVoice platforms, will cut costs, reduce complexity and make video easily and pervasively available to enhance collaboration”
For further information, please visit www.mitel.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
“We explored options and with Mitel and Vidyo we can achieve the same result for a fraction of the cost. We’re pushing the boundaries of how we can collaborate with a solution that is secure, self-contained and simple to use. The power of that is we can now have staff and clinicians working properly and effectively at home with high resolution, high-quality images,” said Mike Press, Assistant Director of NHIS at Nottinghamshire Health Informatics Service, a shared information and communications technology service provider in the U.K. supporting the technology needs of a range of customers within the National Health Service (NHS).
This innovative joint solution was designed with a focus on ease-of-use and neatly incorporates video as integral portion of Mitel’s voice and collaboration platform. The video-enabled solution is incredibly flexible because the Vidyo technology and Mitel’s UCC are software-based. This fact also makes the solution perfectly suited for public, private, and hybrid cloud deployments.
“After shipping two generations of scalable and cost effective systems that can scale personal telepresence from legacy room system to mobile and desktop, we are focused on making our best-in-class conferencing infrastructure even more accessible to end users,” said Ofer Shapiro, co-founder and CEO of Vidyo. “We are excited by the collaboration with Mitel that will put our immersive conferencing infrastructure a click away from any Mitel UC users. The partnership is a perfect example of how the VidyoWorks platform can be used to enhance business workflow.”
The ability to empower collaboration, both internally among employees and externally with partners, suppliers, and customers, is one of the primary needs in today’s business environment. The Mitel/Vidyo integrated solution will enable video conferencing across an organization and beyond. It brings UC driven business-class video conferencing to major mobile devices, including smartphones, tablets and laptops, as well as desktop and in-room systems and across all networks to fully support BYOD initiatives.
“Video is a game changer for business communications, delivering an intuitive real-time experience that boosts productivity and builds closer team cohesion. Getting video to actually work within the organization and especially across other media, on the other hand, has been a challenge,” said Ron Wellard, EVP and GM, Mitel Communications. “Our integrated Vidyo solution, closely tying video into our MiCollab and MiVoice platforms, will cut costs, reduce complexity and make video easily and pervasively available to enhance collaboration”
For further information, please visit www.mitel.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Quicksilver Resources Inc. (KWK) Video Chart for Wednesday, June 26, 2013
KWK is making a double bottom pattern with support around $1.60. On Tuesday, the stock price climbed almost 6 percent, helping turn the indicators and continue a solid upward trend in the MACD, lending to the idea that the support may once again hold.
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
IntelGenx Technologies Corp. (IGXT) Building Portfolio of Proprietary Formulations with Accelerated Path to Development
IntelGenx Technologies has developed a diverse product portfolio based on its novel, proprietary formulations platforms for the treatment of multiple indications. Its three technologies include:
• Multilayer tablet technology, VersaTab™, which allows for the development of oral controlled release products;
• Oral film technology, VersaFilm™, for the immediate delivery of pharmaceutically active substances to the oral cavity for oral or gastro-intestinal absorption; and
• Mucoadhesive technology, AdVersa™, for quick or controlled release to control drug delivery absorption kinetics/rates.
The company has established partnerships with DAVA Pharmaceuticals, Edgemont Pharmaceuticals, Par Pharmaceutical, and RedHill Biopharma, and is also in discussions with several other potential partners for various products.
Because IGTX is developing enhanced formulations of currently marketed therapies, the company has a vantage point over many traditional pharmaceutical and biotechnology companies. IGTX’ products generally require fewer clinical trials to achieve efficacy and safety data for regulatory approval, which means the company can accelerate development and sees lower risk for failure than other industry players.
The company’s VersaFilm™ rizatriptan contains a strip of thin polymeric film comprised of components that are already approved by the U.S. FDA for use in food, pharmaceutical, and cosmetic products. Rizatriptan was developed by Merck & Co. available in 5 and 10 mg tablets (Maxalt) and orally disintegrating tablets. IGXT has formulated rizatriptan as an immediate release oral film based on its VersaFilm technology.
The FDA last week accepted for review IGXT’s New Drug Application (NDA) for IGXT’s VersaFilm™ rizatriptan, which the company believes is the first oral film product for the treatment of migraine for which a 505(b)(2) NDA has been submitted to the FDA. The review is expected to be completed in the first half of 2014.
From a financial standpoint, the company in the first quarter of 2013 marked improvements across the board. Revenue of $0.2 million consisted of $0.1 million of royalty income and $0.1 million of deferred license revenue, both related to Forfivo XL™. Revenue in the first quarter of 2012 was $0.1 million.
The company decreased its total expenses to $0.6 million from $0.7 million in the first quarter of the year prior as clinical study costs incurred in the first quarter of 2012 were not repeated in the first quarter of 2013.
IGXT trimmed its net loss in the first quarter 2013 to $0.05 million from $0.6 million in the first quarter the year prior, maintaining a loss per share of $0.01.
The company expects to be cash flow positive and profitable at the operational level throughout 2013, and as of March 31, 2013, had cash of $2.2 million vs. cash of $2.1 million as of December 31, 2012.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
• Multilayer tablet technology, VersaTab™, which allows for the development of oral controlled release products;
• Oral film technology, VersaFilm™, for the immediate delivery of pharmaceutically active substances to the oral cavity for oral or gastro-intestinal absorption; and
• Mucoadhesive technology, AdVersa™, for quick or controlled release to control drug delivery absorption kinetics/rates.
The company has established partnerships with DAVA Pharmaceuticals, Edgemont Pharmaceuticals, Par Pharmaceutical, and RedHill Biopharma, and is also in discussions with several other potential partners for various products.
Because IGTX is developing enhanced formulations of currently marketed therapies, the company has a vantage point over many traditional pharmaceutical and biotechnology companies. IGTX’ products generally require fewer clinical trials to achieve efficacy and safety data for regulatory approval, which means the company can accelerate development and sees lower risk for failure than other industry players.
The company’s VersaFilm™ rizatriptan contains a strip of thin polymeric film comprised of components that are already approved by the U.S. FDA for use in food, pharmaceutical, and cosmetic products. Rizatriptan was developed by Merck & Co. available in 5 and 10 mg tablets (Maxalt) and orally disintegrating tablets. IGXT has formulated rizatriptan as an immediate release oral film based on its VersaFilm technology.
The FDA last week accepted for review IGXT’s New Drug Application (NDA) for IGXT’s VersaFilm™ rizatriptan, which the company believes is the first oral film product for the treatment of migraine for which a 505(b)(2) NDA has been submitted to the FDA. The review is expected to be completed in the first half of 2014.
From a financial standpoint, the company in the first quarter of 2013 marked improvements across the board. Revenue of $0.2 million consisted of $0.1 million of royalty income and $0.1 million of deferred license revenue, both related to Forfivo XL™. Revenue in the first quarter of 2012 was $0.1 million.
The company decreased its total expenses to $0.6 million from $0.7 million in the first quarter of the year prior as clinical study costs incurred in the first quarter of 2012 were not repeated in the first quarter of 2013.
IGXT trimmed its net loss in the first quarter 2013 to $0.05 million from $0.6 million in the first quarter the year prior, maintaining a loss per share of $0.01.
The company expects to be cash flow positive and profitable at the operational level throughout 2013, and as of March 31, 2013, had cash of $2.2 million vs. cash of $2.1 million as of December 31, 2012.
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Real Goods Solar, Inc. (RSOL) Unit to Deploy 2.2 Megawatt Solar Farm in Vermont
RGS Energy, the commercial and utility division of Real Goods Solar, announced that it has been selected by St. Albans Solar partners LLC to deploy a new 2.2 megawatt solar farm in Saint Albans, the biggest photovoltaic system in Vermont. Project construction is expected to begin in July and should be completed by November.
The solar system will be designed, installed, monitored, and maintained by RGS Energy. It is expected to produce enough power to provide electricity for 400 homes. The new solar power farm will aid the state of Vermont to reach its stated goal of 20% of its power being generated from renewable energy sources by 2017.
The entire amount of the solar energy produced will be purchased through a feed-in tariff under the Standard Offer Program of Vermont’s Sustainably Priced Energy Development (SPEED) program. This program was created in 2005 by the state legislature to promote renewable energy development in the state in order to reach its 20% renewable energy goal by the target date.
Real Goods Solar is one of the country’s pioneering solar energy companies serving residential, commercial, and utility companies. Beginning in 1978 with one of the very first photovoltaic panels sold to the public in the United States, the company has installed more than 14,500 solar power systems representing over 100 megawatts of clean renewable energy.
For further information about Real Goods Solar, please visit either www.RealGoodsSolar.com or www.RGSEnergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
The solar system will be designed, installed, monitored, and maintained by RGS Energy. It is expected to produce enough power to provide electricity for 400 homes. The new solar power farm will aid the state of Vermont to reach its stated goal of 20% of its power being generated from renewable energy sources by 2017.
The entire amount of the solar energy produced will be purchased through a feed-in tariff under the Standard Offer Program of Vermont’s Sustainably Priced Energy Development (SPEED) program. This program was created in 2005 by the state legislature to promote renewable energy development in the state in order to reach its 20% renewable energy goal by the target date.
Real Goods Solar is one of the country’s pioneering solar energy companies serving residential, commercial, and utility companies. Beginning in 1978 with one of the very first photovoltaic panels sold to the public in the United States, the company has installed more than 14,500 solar power systems representing over 100 megawatts of clean renewable energy.
For further information about Real Goods Solar, please visit either www.RealGoodsSolar.com or www.RGSEnergy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Chanticleer Holdings, Inc. (HOTR) Anticipates Opening 5th Hooters Restaurant in South Africa as Part of Broader Expansion Plans
Chanticleer Holdings is the owner and operator of Hooters restaurants on an international scale. The company’s growth strategy is to expand the Hooters brand in emerging markets via partnership and/or acquisition of Hooters restaurants.
The company currently has restaurants planted in South Africa, Australia, and Hungary, selecting territories with strong local market dynamics based on economic growth and demographics.
In December 2009, HOTR opened its first South Africa Restaurant in Durban, and by February 2012 had opened its fourth restaurant in Emperor’s Palace Casino in South Africa, which is operated by a management company formed to manage all South Africa units. The fifth restaurant in South Africa is slated to open this year in Pretoria.
In the fourth quarter of 2012, HOT implemented price increases, an updated menu, and improved the appeal of certain restaurants in South Africa. The units generated revenue of $6.2 million, representing a significant majority of HOTR’s full-year 2012 total revenues of $6.9 million.
HOTR overarching goal is to have 10 Hooters restaurants operating in 2013, though it believes that based on current exclusive international territories it could grow to have more than 75 Hooters locations.
Specific to South Africa, the company sees full market opportunity in the area at 20 restaurants and has eyes on new potential locations in Cape Town Waterfront, Secunda, and Bloemfontein.
For more information, visit www.chanticleerholdings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
The company currently has restaurants planted in South Africa, Australia, and Hungary, selecting territories with strong local market dynamics based on economic growth and demographics.
In December 2009, HOTR opened its first South Africa Restaurant in Durban, and by February 2012 had opened its fourth restaurant in Emperor’s Palace Casino in South Africa, which is operated by a management company formed to manage all South Africa units. The fifth restaurant in South Africa is slated to open this year in Pretoria.
In the fourth quarter of 2012, HOT implemented price increases, an updated menu, and improved the appeal of certain restaurants in South Africa. The units generated revenue of $6.2 million, representing a significant majority of HOTR’s full-year 2012 total revenues of $6.9 million.
HOTR overarching goal is to have 10 Hooters restaurants operating in 2013, though it believes that based on current exclusive international territories it could grow to have more than 75 Hooters locations.
Specific to South Africa, the company sees full market opportunity in the area at 20 restaurants and has eyes on new potential locations in Cape Town Waterfront, Secunda, and Bloemfontein.
For more information, visit www.chanticleerholdings.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Tuesday, June 25, 2013
Laura Janke Jaeger Joins Virtual Piggy, Inc. (VPIG) as General Counsel
Virtual Piggy, an e-commerce solution designed to equip teens with financial management tools, announced today that Laura Janke Jaeger has been appointed as General Counsel.
“Virtual Piggy is a fast growing company with a unique business model,” said Ms. Jaeger. “I’m thrilled to be part of the executive management team and help Virtual Piggy become a household name across the globe.”
Virtual Piggy promotes financial management while empowering people under 18 to make purchasing, saving, and other money management decisions for themselves, within boundaries setup by parents. The technology is available online or via mobile, and is always 100% free.
With over 20 years of experience on advising board and management teams, Ms. Jaeger is well versed in working on strategic and financing activities, as well as transactional and other corporate and regulatory issues. She has served as the Senior VP and General Counsel of Elandia, Inc., as Corporate Vice President of Fortune 150 Cendant Corporation, and as General Counsel of Winstar International, Inc.
Prior to her in-house roles at these public companies, Ms. Jaeger was a corporate and transactional associate at top New York law firms Simpson, Thatcher & Bartlett, and White & Case. She is a graduate of Georgetown Law and the University of Notre Dame, and is licensed to practice law in England as well as New York.
Virtual Piggy’s founder, Dr. Jo Webber, remarked, “I’m excited that Laura had decided to join the executive team. Her broad legal expertise at an international level is already proving to be invaluable to us as we expand domestically and globally.”
For more information, visit www.virtualpiggy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
“Virtual Piggy is a fast growing company with a unique business model,” said Ms. Jaeger. “I’m thrilled to be part of the executive management team and help Virtual Piggy become a household name across the globe.”
Virtual Piggy promotes financial management while empowering people under 18 to make purchasing, saving, and other money management decisions for themselves, within boundaries setup by parents. The technology is available online or via mobile, and is always 100% free.
With over 20 years of experience on advising board and management teams, Ms. Jaeger is well versed in working on strategic and financing activities, as well as transactional and other corporate and regulatory issues. She has served as the Senior VP and General Counsel of Elandia, Inc., as Corporate Vice President of Fortune 150 Cendant Corporation, and as General Counsel of Winstar International, Inc.
Prior to her in-house roles at these public companies, Ms. Jaeger was a corporate and transactional associate at top New York law firms Simpson, Thatcher & Bartlett, and White & Case. She is a graduate of Georgetown Law and the University of Notre Dame, and is licensed to practice law in England as well as New York.
Virtual Piggy’s founder, Dr. Jo Webber, remarked, “I’m excited that Laura had decided to join the executive team. Her broad legal expertise at an international level is already proving to be invaluable to us as we expand domestically and globally.”
For more information, visit www.virtualpiggy.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Anthera Pharmaceuticals, Inc. (ANTH) Initiates BRIGHT-SC Phase 2 Clinical Study of Blisibimod for Treating IgA Nephropathy
Biopharmaceutical company Anthera Pharmaceuticals has announced the initiation of the BRIGHT-SC Phase 2 study of blisibimod, which is a novel inhibitor of B-cell activating factor (BAFF) for treating IgA nephropathy. A chronic autoimmune renal disease, IgA nephropathy is characterized by proteinuria and progression to end-stage renal disease.
A multicenter, placebo-controlled, double-blind Phase 2 clinical study, the BRIGHT-SC trial is anticipated to enroll a minimum of 48 patients from Asia Pacific geographies, who will then be randomized into one active treatment arm or one placebo arm. The study’s primary endpoint will be a reduction in proteinuria at 32 weeks. After the patients have completed eight weeks of therapy, Anthera intends to conduct an interim analysis of proteinuria. The study’s secondary endpoints will include the effects of blisibimod on estimated glomerular filtration rate (eGFR), plasma B cells and other kidney disease biomarkers.
Anthera met with the United States Food and Drug Administration (FDA) in May of this year to discuss the future of the IgA nephropathy development plan. The company has been encouraged by the outcome of its pre-Investigational New Drug meeting with the FDA, and the agency’s reception was positive regarding the use of proteinuria as a primary endpoint in studies of IgA nephropathy. The data from the BRIGHT-SC study design will aid Anthera in its efforts to obtain an accelerated approval for blisibimod in this potential orphan indication.
Anthera will meet with the Japanese Pharmaceutical Medical Devices Agency in the coming weeks to explore development strategies in Japan.
For more information, visit www.anthera.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
A multicenter, placebo-controlled, double-blind Phase 2 clinical study, the BRIGHT-SC trial is anticipated to enroll a minimum of 48 patients from Asia Pacific geographies, who will then be randomized into one active treatment arm or one placebo arm. The study’s primary endpoint will be a reduction in proteinuria at 32 weeks. After the patients have completed eight weeks of therapy, Anthera intends to conduct an interim analysis of proteinuria. The study’s secondary endpoints will include the effects of blisibimod on estimated glomerular filtration rate (eGFR), plasma B cells and other kidney disease biomarkers.
Anthera met with the United States Food and Drug Administration (FDA) in May of this year to discuss the future of the IgA nephropathy development plan. The company has been encouraged by the outcome of its pre-Investigational New Drug meeting with the FDA, and the agency’s reception was positive regarding the use of proteinuria as a primary endpoint in studies of IgA nephropathy. The data from the BRIGHT-SC study design will aid Anthera in its efforts to obtain an accelerated approval for blisibimod in this potential orphan indication.
Anthera will meet with the Japanese Pharmaceutical Medical Devices Agency in the coming weeks to explore development strategies in Japan.
For more information, visit www.anthera.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Biozoom, Inc. (BIZM) Reaches Milestone with Commercial Production of Biofeedback Scanner
Biozoom, a technology development company and creator of the world’s first portable, handheld device for real-time biofeedback scanner, has moved the device into commercial production with the first shipment slated to arrive in September.
“The Biozoom scanner has captured the attention of so many organizations that production has moved from prototype to commercial scale,” Biozoom CTO Dr. Wolfgang Kocher stated in the press release. “They will be used to extend our test marketing with key commercial, healthcare and governmental entities.”
The Biozoom scanner non-invasively measures and analyzes biomarkers to understand, manage, and improve the user’s health and wellness. With the ability to measure anti-aging factors such as skin moisture and nutritional absorption, the device also has application in the cosmetics industry. The first commercially produced scanners will be used for large-scale studies by cosmetics and consumer goods producers, as well as large employers.
“… The scanner gives new insight into the overall health and wellbeing of users by measuring antioxidant levels, stress responses and much more. Several large organizations have expressed interest in using the scanner to understand and support the health of their employees,” said Dr. Kocher. “By focusing on wellness and disease prevention, they can use Biozoom to help drive down healthcare costs and absenteeism due to preventable illness.”
Biozoom said the prototype units have been validated in clinical trials and have already been implemented in several European institutions.
“We have reached an exciting milestone,” said CEO Hardy Hoheisel. “The first commercially produced units will include all of the patented components and will prove the feasibility of low-cost mass production.”
For more information, visit www.biozoom.net
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
“The Biozoom scanner has captured the attention of so many organizations that production has moved from prototype to commercial scale,” Biozoom CTO Dr. Wolfgang Kocher stated in the press release. “They will be used to extend our test marketing with key commercial, healthcare and governmental entities.”
The Biozoom scanner non-invasively measures and analyzes biomarkers to understand, manage, and improve the user’s health and wellness. With the ability to measure anti-aging factors such as skin moisture and nutritional absorption, the device also has application in the cosmetics industry. The first commercially produced scanners will be used for large-scale studies by cosmetics and consumer goods producers, as well as large employers.
“… The scanner gives new insight into the overall health and wellbeing of users by measuring antioxidant levels, stress responses and much more. Several large organizations have expressed interest in using the scanner to understand and support the health of their employees,” said Dr. Kocher. “By focusing on wellness and disease prevention, they can use Biozoom to help drive down healthcare costs and absenteeism due to preventable illness.”
Biozoom said the prototype units have been validated in clinical trials and have already been implemented in several European institutions.
“We have reached an exciting milestone,” said CEO Hardy Hoheisel. “The first commercially produced units will include all of the patented components and will prove the feasibility of low-cost mass production.”
For more information, visit www.biozoom.net
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Cardium Therapeutics, Inc. (CXM) Positioned to Advance Leading Products with Experienced Leadership at the Helm
Cardium Therapeutics has established a diversified portfolio of medical products with large market potential. Armed with a capital-efficient, asset-based business strategy, the company is positioned to continue to build its portfolio with balanced risk/return opportunities in a variety of markets and is working to secure approval for marketing and sale in South Korea and the European Union.
Company CEO Christopher J. Reinhard founded the company in December 2003, backed by nearly 15 years of focus on the commercial development of cardiovascular growth factor therapeutics.
Under Reinhard’s leadership, Cardium is working to advance its ASPIRE Generx® clinical study at major medical centers in Russia. The company is also seeking clinical development and commercialization partners for Generx® in countries such as India, China and Brazil.
The Generx® product candidate is a minimally invasive DNA-based angiogenic growth factor therapy in development for the treatment of patients with advanced coronary artery disease. The product is being developed for international markets as an alternative treatment for patients who may not have access to surgical revascularization procedures such as coronary artery bypass surgery and angioplasty/stents.
Cardium’s Excellagen® is a syringe-based collagen gel designed to speed the growth of granulation tissue and to trigger the wound healing process. The product is FDA-cleared as treatment of neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical wounds, and other dermal wounds. Cardium is seeking commercialization partners for the marketing and sale of the product both domestically and internationally.
Cardium’s To Go Brands® develops, markets, and sells more than 25 products in support of a healthy lifestyle. The product line includes nutraceutical powder mixes, supplements, and chews sold through mass, food, and drug retailers.
Cardium is working to broaden and grow its To Go Brands® nutraceutical supplement brand platform and continues to review acquisitions of other companies and businesses to identify additional product opportunities and technologies.
For more information, visit www.cardiumthx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Company CEO Christopher J. Reinhard founded the company in December 2003, backed by nearly 15 years of focus on the commercial development of cardiovascular growth factor therapeutics.
Under Reinhard’s leadership, Cardium is working to advance its ASPIRE Generx® clinical study at major medical centers in Russia. The company is also seeking clinical development and commercialization partners for Generx® in countries such as India, China and Brazil.
The Generx® product candidate is a minimally invasive DNA-based angiogenic growth factor therapy in development for the treatment of patients with advanced coronary artery disease. The product is being developed for international markets as an alternative treatment for patients who may not have access to surgical revascularization procedures such as coronary artery bypass surgery and angioplasty/stents.
Cardium’s Excellagen® is a syringe-based collagen gel designed to speed the growth of granulation tissue and to trigger the wound healing process. The product is FDA-cleared as treatment of neuropathic and diabetic foot ulcers, pressure ulcers, venous ulcers, surgical wounds, and other dermal wounds. Cardium is seeking commercialization partners for the marketing and sale of the product both domestically and internationally.
Cardium’s To Go Brands® develops, markets, and sells more than 25 products in support of a healthy lifestyle. The product line includes nutraceutical powder mixes, supplements, and chews sold through mass, food, and drug retailers.
Cardium is working to broaden and grow its To Go Brands® nutraceutical supplement brand platform and continues to review acquisitions of other companies and businesses to identify additional product opportunities and technologies.
For more information, visit www.cardiumthx.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Frontier Communications Corp. (FTR) Announces Partnership with Asurion to Offer No-Contract, Comprehensive Coverage Electronic Equipment Protection Plans
Frontier Communications, offering broadband, voice, satellite video, wireless Internet data access, entertainment services, data security solutions through Frontier Secure, and bundled offerings, yesterday announced that Frontier Secure now offers residential and small business customers comprehensive equipment protection through Asurion, the leading global technology protection company.
Frontier Secure offers its customers protection for their digital lives through the use of a suit of services that guard against identity theft, ensuring 24/7 premium technical support and offering data security and backup. Frontier Secure will now offer repair/replacement plans which cover most PCs and laptops, gaming consoles, TVs (LED, LCD and Plasma), iPads, eReaders, tablets, printers, and more. The service will require no contract; customers have the option to obtain coverage for one or more personal devices, their whole home, their offices, or small businesses for a simple low monthly fee.
Kelly Morgan, Vice President and General Manager, Frontier Secure, commented “Consumers want connectivity, reliability, cost savings and the peace of mind that comes from knowing valuable electronic equipment is protected. Frontier Secure Equipment Protection Plans keep the vital electronic equipment relied on by families and small businesses up and running.” Additional savings are obtained when Equipment Protection Plans are bundled with other Frontier Secure products and services, an option the company makes available throughout the United States.
Upon the purchase of an Equipment Protection Plan, the customer receives a dedicated phone number to U.S.-based customer service experts. The claim process is simple and can be completed easily for those with home or office equipment and may include a service appointment from a certified professional and device repair or replacement, depending on the type of equipment and repairs needed. Specific items can also benefit from pre-paid shipping, including, laptops, tablets, eReaders, gaming consoles, and TVs (37″ and under).
Bettie Colombo, spokesperson for Asurion added, “One in three computers experiences a failure over its useful life. With Frontier Secure and this product, `fear of failure’ is a thing of the past.”
Frontier Secure offers a full portfolio of products and services to protect every aspect of your digital life, including unlimited cloud Backup & Sharing and 24/7 U.S.-based Premium Technical Support. For more information, call 1-888-620-3663.
For additional information on Frontier Communications, please visit www.frontier.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Frontier Secure offers its customers protection for their digital lives through the use of a suit of services that guard against identity theft, ensuring 24/7 premium technical support and offering data security and backup. Frontier Secure will now offer repair/replacement plans which cover most PCs and laptops, gaming consoles, TVs (LED, LCD and Plasma), iPads, eReaders, tablets, printers, and more. The service will require no contract; customers have the option to obtain coverage for one or more personal devices, their whole home, their offices, or small businesses for a simple low monthly fee.
Kelly Morgan, Vice President and General Manager, Frontier Secure, commented “Consumers want connectivity, reliability, cost savings and the peace of mind that comes from knowing valuable electronic equipment is protected. Frontier Secure Equipment Protection Plans keep the vital electronic equipment relied on by families and small businesses up and running.” Additional savings are obtained when Equipment Protection Plans are bundled with other Frontier Secure products and services, an option the company makes available throughout the United States.
Upon the purchase of an Equipment Protection Plan, the customer receives a dedicated phone number to U.S.-based customer service experts. The claim process is simple and can be completed easily for those with home or office equipment and may include a service appointment from a certified professional and device repair or replacement, depending on the type of equipment and repairs needed. Specific items can also benefit from pre-paid shipping, including, laptops, tablets, eReaders, gaming consoles, and TVs (37″ and under).
Bettie Colombo, spokesperson for Asurion added, “One in three computers experiences a failure over its useful life. With Frontier Secure and this product, `fear of failure’ is a thing of the past.”
Frontier Secure offers a full portfolio of products and services to protect every aspect of your digital life, including unlimited cloud Backup & Sharing and 24/7 U.S.-based Premium Technical Support. For more information, call 1-888-620-3663.
For additional information on Frontier Communications, please visit www.frontier.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Accuray Inc. (ARAY) Reports First U.S. Center Treats Patient with New TomoHDA System
Radiation oncology company Accuray today announced that the Tulsa Cancer Institute in Oklahoma is the first U.S. center to treat a cancer patient with its TomoHDA System. This product is the latest and most advanced innovation in the Tomo Therapy product line designed to treat the full range of cancer patients. Earlier this month, the System was installed at a center in France where the first European patient was treated with the device.
Among the TomoHDA System’s numerous benefits are streamlined daily 3D CT image guidance for accurate treatment delivery, faster treatment times, and the ability to create treatment plans that specifically target the cancer while sparing the surrounding healthy tissue. The TomoHDA now only allows cancer treatment centers to treat more patients daily, but also to maintain the patient’s quality of life as much as possible.
Daron Street M.D. of the Tulsa Cancer Institute said, “The flexibility of the TomoHDA System allows our physicians to not only treat common cancers but also tackle more complicated cancers in the most efficient, accurate way possible.” This should offer their patients the opportunity for the best possible clinical outcomes.
Accuray is a radiation oncology company that develops, manufactures, and sells innovative treatment solutions that set the standard of care in helping patients live longer, healthier lives. The company’s leading edge technologies deliver the full range of radiation therapy and radiosurgery treatments.
For additional information about Accuray, visit www.accuray.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Among the TomoHDA System’s numerous benefits are streamlined daily 3D CT image guidance for accurate treatment delivery, faster treatment times, and the ability to create treatment plans that specifically target the cancer while sparing the surrounding healthy tissue. The TomoHDA now only allows cancer treatment centers to treat more patients daily, but also to maintain the patient’s quality of life as much as possible.
Daron Street M.D. of the Tulsa Cancer Institute said, “The flexibility of the TomoHDA System allows our physicians to not only treat common cancers but also tackle more complicated cancers in the most efficient, accurate way possible.” This should offer their patients the opportunity for the best possible clinical outcomes.
Accuray is a radiation oncology company that develops, manufactures, and sells innovative treatment solutions that set the standard of care in helping patients live longer, healthier lives. The company’s leading edge technologies deliver the full range of radiation therapy and radiosurgery treatments.
For additional information about Accuray, visit www.accuray.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
U.S. Geothermal, Inc. (HTM) Completes Initial Production Well Near Guatemala City, Better Economics Realized
U.S. Geothermal is on the front lines of making the abundant renewable energy potential inherent in geothermal a reality via their portfolio of power projects in Idaho, Nevada, Oregon, and Guatemala, where today news is breaking from the company’s wholly-owned subsidiary, U.S. Geothermal Guatemala, S.A., as drilling on the EC-1 (which began on April 29) at their advanced-stage El Ceibillo Project has been completed to a depth of just over 4.8k feet.
President and COO of HTM, Doug Glaspey, could not contain his enthusiasm over the preliminary results from this first production well at El Ceibillo, which is located just over 6.5 miles southwest of Guatemala City, with some 24.7k acres of prime territory smack in the middle of the Aqua/Pacaya twin volcano complex. The final depth was a good 1.5k feet deeper than initially planned on the EC-1, due in large part to exceptional drilling conditions and geology, which allowed the company to chase the hotter depth and still manage to pull it all off within budget.
We are talking a bottom-hole temp of 491 degrees Fahrenheit (255 Celsius) with a gradient ramp around 7.1DegF/100 feet. Taken in light of the 392DegF and greater encountered as early as approximately 2.6k feet down the hole, we are looking at a 2.2k-foot high-temp reservoir interval. These are superb numbers and they spell a bright future for the optimally-located El Ceibillo, just outside the energy-hungry capital, whose population is now upwards of 1.075M.
The company ran into some permeability on the way down and ended up running a slotted liner to support production operations, with the subsequent cleanout showing really strong indicators that a formal testing was in order. HTM is now looking at a 4 to 6 week window within which to execute further testing and they are currently focused squarely on getting the necessary flow test hardware fabricated and in place.
The goal to complete a 25-megawatt flash steam power plant is one step closer with today’s news, and the potential of the concession as a whole is immense, with a projected 50MW capacity easily achievable, out beyond the 15-year term PPA framework figure of 25MW, established by the MOU signed back in October of 2012. Glaspey is obviously pleased with the reservoir temps, which are considerably higher than initially anticipated and the optimal downhole geology, combined with the favorable external logistics looks very good for HTM shareholders.
Given that the drilling conditions are demonstrably good enough to bring down projected costs of future production drilling, HTM is in the pole position here, with easy drilling ahead into some seriously hot ground. Premium economics and a massive consumer market right nearby spells big potential for the company’s Guatemala operations and investors will be eager to hear further reports as the test flow equipment is readied, then implemented at El Ceibillo in the coming weeks.
HTM has a total acreage position of some 69.5k acres across all six of their advanced stage projects and is a great way to get into the geothermal game.
For more information on U.S. Geothermal, visit www.USGeothermal.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
President and COO of HTM, Doug Glaspey, could not contain his enthusiasm over the preliminary results from this first production well at El Ceibillo, which is located just over 6.5 miles southwest of Guatemala City, with some 24.7k acres of prime territory smack in the middle of the Aqua/Pacaya twin volcano complex. The final depth was a good 1.5k feet deeper than initially planned on the EC-1, due in large part to exceptional drilling conditions and geology, which allowed the company to chase the hotter depth and still manage to pull it all off within budget.
We are talking a bottom-hole temp of 491 degrees Fahrenheit (255 Celsius) with a gradient ramp around 7.1DegF/100 feet. Taken in light of the 392DegF and greater encountered as early as approximately 2.6k feet down the hole, we are looking at a 2.2k-foot high-temp reservoir interval. These are superb numbers and they spell a bright future for the optimally-located El Ceibillo, just outside the energy-hungry capital, whose population is now upwards of 1.075M.
The company ran into some permeability on the way down and ended up running a slotted liner to support production operations, with the subsequent cleanout showing really strong indicators that a formal testing was in order. HTM is now looking at a 4 to 6 week window within which to execute further testing and they are currently focused squarely on getting the necessary flow test hardware fabricated and in place.
The goal to complete a 25-megawatt flash steam power plant is one step closer with today’s news, and the potential of the concession as a whole is immense, with a projected 50MW capacity easily achievable, out beyond the 15-year term PPA framework figure of 25MW, established by the MOU signed back in October of 2012. Glaspey is obviously pleased with the reservoir temps, which are considerably higher than initially anticipated and the optimal downhole geology, combined with the favorable external logistics looks very good for HTM shareholders.
Given that the drilling conditions are demonstrably good enough to bring down projected costs of future production drilling, HTM is in the pole position here, with easy drilling ahead into some seriously hot ground. Premium economics and a massive consumer market right nearby spells big potential for the company’s Guatemala operations and investors will be eager to hear further reports as the test flow equipment is readied, then implemented at El Ceibillo in the coming weeks.
HTM has a total acreage position of some 69.5k acres across all six of their advanced stage projects and is a great way to get into the geothermal game.
For more information on U.S. Geothermal, visit www.USGeothermal.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Monday, June 24, 2013
United States Antimony Corp. (UAMY) Leases San Jose Antimony Mines, Expanding Antimony Pipeline in Mexico
United States Antimony is breaking into a larger production envelope with today’s news that they have secured a one-year (with renewals) lease on the San Jose Antimony Mines, including the concessions themselves, equipment, the mill, and accoutrements like the on-site administrative office and assay lab, as well as a small hospital, man-camp, railroad siding, shop, and the warehouses.
This is a quality, furnished asset to add to UAMY’s production pipeline, which already consists of beautifully integrated operations that span mining, milling, smelting, transportation, and the eventual sales. The company has already assembled an impressive footprint in Mexico and news of this latest acquisition, in the State of San Luis Potosi (near Wadley), represents a very good deal for shareholders at $25k for the first month and $30k for each thereafter (during the first six months, having started June 20).
Letter in hand from the owner, UAMY is set to commence operations and projects resolution of a definitive agreement by the end of the first week of July, clearly raring to go at the new digs. With supply on the global market dwindling due to reduced output from the major supplier, China (whose domestic consumption has eaten away at the volume), 44-year industry veteran UAMY is strategically positioned with this acreage in Mexico.
This company has been producing various antimony, silver, and gold products for quite some time (as well as taking in other raw materials from sources outside China) and actually got started up in Montana. Against the backdrop of today’s announcement we have a recent acceleration of activity at their rapidly developing Los Juarez property and a doubling of the capacity at their Puerto Blanco antimony flotation mill located in Guanajuato (back in April).
The main mineralized zone at the new lease is roughly 1.24 miles by 0.62 miles and according to USGS data on the San Jose mines, by 1943, more antimony had come out of here than any other district in the whole of Mexico, at just over 57.6k metric tons. Few deposits on earth are better by this comparison and since then a significant additional quantity has come out of the mine. With some 300 miles of underground workings and a historical production record where antimony was hand-sorted for high grade to be sent to the smelter, there are extensive dump materials on-site as well.
From 2010 on the company bought and smelted roughly 481k pounds of antimony from the mine, and going off of modifications to the old 500 tons/day plant (20-25% recovery in the form of a low-grade concentrate) made and tested last year, the company is looking at recovery in the range of 40-50%, or as high as 55% antimony concentrate in reduced volume operations. While no reserves are currently claimed by the company here, mass dumps from over 50 years worth of mining and an economically viable milling workflow that puts the lower grade targets well in hand means UAMY is set up nicely to generate some serious production. The company is moving fast to get the permitting out of the way so they can start running the lower-grade mineralization, shipping out the higher-grade stuff to their own smelter at Estacion Madero near Coahuila, again expressing the exceptional economics of the company’s vertically integrated antimony pipeline.
To get a closer look at United States Antimony, please visit www.USAntimony.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
This is a quality, furnished asset to add to UAMY’s production pipeline, which already consists of beautifully integrated operations that span mining, milling, smelting, transportation, and the eventual sales. The company has already assembled an impressive footprint in Mexico and news of this latest acquisition, in the State of San Luis Potosi (near Wadley), represents a very good deal for shareholders at $25k for the first month and $30k for each thereafter (during the first six months, having started June 20).
Letter in hand from the owner, UAMY is set to commence operations and projects resolution of a definitive agreement by the end of the first week of July, clearly raring to go at the new digs. With supply on the global market dwindling due to reduced output from the major supplier, China (whose domestic consumption has eaten away at the volume), 44-year industry veteran UAMY is strategically positioned with this acreage in Mexico.
This company has been producing various antimony, silver, and gold products for quite some time (as well as taking in other raw materials from sources outside China) and actually got started up in Montana. Against the backdrop of today’s announcement we have a recent acceleration of activity at their rapidly developing Los Juarez property and a doubling of the capacity at their Puerto Blanco antimony flotation mill located in Guanajuato (back in April).
The main mineralized zone at the new lease is roughly 1.24 miles by 0.62 miles and according to USGS data on the San Jose mines, by 1943, more antimony had come out of here than any other district in the whole of Mexico, at just over 57.6k metric tons. Few deposits on earth are better by this comparison and since then a significant additional quantity has come out of the mine. With some 300 miles of underground workings and a historical production record where antimony was hand-sorted for high grade to be sent to the smelter, there are extensive dump materials on-site as well.
From 2010 on the company bought and smelted roughly 481k pounds of antimony from the mine, and going off of modifications to the old 500 tons/day plant (20-25% recovery in the form of a low-grade concentrate) made and tested last year, the company is looking at recovery in the range of 40-50%, or as high as 55% antimony concentrate in reduced volume operations. While no reserves are currently claimed by the company here, mass dumps from over 50 years worth of mining and an economically viable milling workflow that puts the lower grade targets well in hand means UAMY is set up nicely to generate some serious production. The company is moving fast to get the permitting out of the way so they can start running the lower-grade mineralization, shipping out the higher-grade stuff to their own smelter at Estacion Madero near Coahuila, again expressing the exceptional economics of the company’s vertically integrated antimony pipeline.
To get a closer look at United States Antimony, please visit www.USAntimony.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Smith Micro Software, Inc. (SMSI) Launches Unveils ScatterShow, Software for Displaying Life’s Memorable Moments in Motion
Smith Micro Software Productivity and Graphics Group today unveiled their new software ScatterShowTM, an innovative and easy-to-use software application that allows anyone to create and share their own interactive photo slideshows with ease. ScatterShow, utilizing the ability to explore and load photos from your tablet, computer, smartphone, and Instagram®, enables users to create stunning slideshows to share with friends and family right out of the box.
Visit www.scattershow.smithmicro.com to learn more about the software.
Unlike any photo sharing or slideshow application available today, ScatterShow sets itself apart through its innovative upload features and an animation experience deeply rooted in Smith Micro’s long history of outstanding motion software.
Benefits of ScatterShow Software:
• Provides a simple way to explore, store, and share photographs with a modern motion arrangement
• User-friendly software program for all skill levels — create your own hand-crafted slideshows or utilize pre-loaded templates
• Simple photo uploading from a variety of devices
• Easy exporting to share on Facebook, YouTube or any HTML5-enabled webpage
ScatterShow Key Features:
• Tons of pre-loaded and customizable animations and visual effects
• A spectrum of available photo filters to enhance and beautify your images
• Option to add background images or music
“Today, photos mean much more to people than just memories; now every photo has a story to tell. Our goal with ScatterShow was to create an innovative and rewarding way of sharing those stories,” commented Jordan Bentley, product manager for Smith Micro Software. “ScatterShow can transform a simple book of photos into a memorable sharing experience, allowing you to break free from the old, static photo album and inspire others with amazing motion and effects.”
For an optimized ScatterShow experience, social media devotees can search Instagram users and hashtags. Additionally, Smith Micro’s Quicklink technology makes use of wireless networks to pull photos right off of users’ Android smartphones straight into ScatterShow, allowing for quick and seamless photo uploads.
For more information on Smith Micro Software, visit www.smithmicro.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Visit www.scattershow.smithmicro.com to learn more about the software.
Unlike any photo sharing or slideshow application available today, ScatterShow sets itself apart through its innovative upload features and an animation experience deeply rooted in Smith Micro’s long history of outstanding motion software.
Benefits of ScatterShow Software:
• Provides a simple way to explore, store, and share photographs with a modern motion arrangement
• User-friendly software program for all skill levels — create your own hand-crafted slideshows or utilize pre-loaded templates
• Simple photo uploading from a variety of devices
• Easy exporting to share on Facebook, YouTube or any HTML5-enabled webpage
ScatterShow Key Features:
• Tons of pre-loaded and customizable animations and visual effects
• A spectrum of available photo filters to enhance and beautify your images
• Option to add background images or music
“Today, photos mean much more to people than just memories; now every photo has a story to tell. Our goal with ScatterShow was to create an innovative and rewarding way of sharing those stories,” commented Jordan Bentley, product manager for Smith Micro Software. “ScatterShow can transform a simple book of photos into a memorable sharing experience, allowing you to break free from the old, static photo album and inspire others with amazing motion and effects.”
For an optimized ScatterShow experience, social media devotees can search Instagram users and hashtags. Additionally, Smith Micro’s Quicklink technology makes use of wireless networks to pull photos right off of users’ Android smartphones straight into ScatterShow, allowing for quick and seamless photo uploads.
For more information on Smith Micro Software, visit www.smithmicro.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Jameson Stanford Resources Corp. (JMSN) Works Spor Mountain and Ogden Bay Minerals in Utah
Jameson Stanford, a mineral exploration and development company, is working important mineral sites in Utah, where it is focused on gold, silver, and a number of other minerals. Dealing with natural resources today requires a balance of corporate and environmental responsibility. Jameson Stanford is pioneering new extraction and exploration methodologies to ensure minimal impact on the land and maximum return on investments. Sport Mountain and Ogden Bay Minerals are two of their current active sites.
The company’s Spor Mountain project consists of 9 lode mining claims and 3 metalliferous mineral lease sections located in Juab County in west central Utah, approximately 50 miles northwest of the small town of Delta and near the Dugway Military Proving Grounds. The project covers a total of 2,098 acres, and preliminary geological analysis and two prospect pit excavations suggest total inferred reserves at the site may ultimately involve more than 4,000,000 ounces of silver and commercial concentrations of beryllium, along with other precious and base metals. Planned project activities at Spor Mountain in 2013 will focus on prospecting, exploration, and development. Assuming economic feasibility, the company anticipates startup of production/mining operations in 2014.
Ogden Bay Minerals is a developing mineral excavation project on federal protected wetlands, canals, and river systems across 25 square miles of land known as North Delta, located in West Ogden, Utah. The project contains large deposits of alluvial mineral deposits that are created and replenished from 125 miles of river flow from the nearby Wasatch Mountain Range. These alluvial mineral deposits have an approximate average grade of 1.85 grams/ton gold and 200-1,200 grams per ton zircon. Indications are that gold, silver, and other commercial metals and minerals can be efficiently extracted by gravity separation methods. The company estimates that the project can produce up to approximately 100,000 metric tons of saleable silica product per year.
For additional information, visit www.JamesonStanford.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
The company’s Spor Mountain project consists of 9 lode mining claims and 3 metalliferous mineral lease sections located in Juab County in west central Utah, approximately 50 miles northwest of the small town of Delta and near the Dugway Military Proving Grounds. The project covers a total of 2,098 acres, and preliminary geological analysis and two prospect pit excavations suggest total inferred reserves at the site may ultimately involve more than 4,000,000 ounces of silver and commercial concentrations of beryllium, along with other precious and base metals. Planned project activities at Spor Mountain in 2013 will focus on prospecting, exploration, and development. Assuming economic feasibility, the company anticipates startup of production/mining operations in 2014.
Ogden Bay Minerals is a developing mineral excavation project on federal protected wetlands, canals, and river systems across 25 square miles of land known as North Delta, located in West Ogden, Utah. The project contains large deposits of alluvial mineral deposits that are created and replenished from 125 miles of river flow from the nearby Wasatch Mountain Range. These alluvial mineral deposits have an approximate average grade of 1.85 grams/ton gold and 200-1,200 grams per ton zircon. Indications are that gold, silver, and other commercial metals and minerals can be efficiently extracted by gravity separation methods. The company estimates that the project can produce up to approximately 100,000 metric tons of saleable silica product per year.
For additional information, visit www.JamesonStanford.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Pitooey! Inc. (PTOO) Harnessing Opportunities in Growing Digital Ad, Mobile App Markets
The rapid proliferation of smartphone and tablet demand has created an infinitely large space for mobile app innovation. Mobile app downloads are expected to reach 60 billion in 2012 and jump to 108 billion by 2017 as consumers shift to using mobile devices for entertainment as well as to purchase goods and services.
This growth has also subsequently altered the advertising landscape, which now has a heavy focus on digital platforms as marketers seek out the most effective and far-reaching forms of advertising available. Digital ad spending is expected to increase 15.1 percent to $118.4 billion in 2013, representing a 21.7 percent share of advertising spending across all media for the full year. By 2016, digital ad spending is expected to surpass 25 percent.
Digital marketing agency Pitooey! leverages its proprietary technology to take advantage of the tremendous opportunities within the digital advertising and mobile app spaces. The company is working to strengthen its own presence on the Internet, but also aims to help other companies reach target consumers via digital ad while connecting those consumers with businesses of their choice.
The company’s Pitooey! Mobile, Inc. subsidiary represents a consumer-centric, profile-based search engine within in a mobile app, designed to assist users in creating efficient and organized, business-to-consumer interaction. PITOOEY! app users create a personalized profile of their favorite businesses and then subscribe to these businesses. This enables the user to receive deals and/or updates on those specific businesses only from businesses of their choice, be it retail store, hotel, entertainment venues, or more.
PITOOEY!’s growth plan is to expand its mobile app technology into strategic geographic markets and key metropolitan areas where it can add relevant data (searchable business databases) in stages, and thus monitor and manage growth.
For more information, visit www.pitooey.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
This growth has also subsequently altered the advertising landscape, which now has a heavy focus on digital platforms as marketers seek out the most effective and far-reaching forms of advertising available. Digital ad spending is expected to increase 15.1 percent to $118.4 billion in 2013, representing a 21.7 percent share of advertising spending across all media for the full year. By 2016, digital ad spending is expected to surpass 25 percent.
Digital marketing agency Pitooey! leverages its proprietary technology to take advantage of the tremendous opportunities within the digital advertising and mobile app spaces. The company is working to strengthen its own presence on the Internet, but also aims to help other companies reach target consumers via digital ad while connecting those consumers with businesses of their choice.
The company’s Pitooey! Mobile, Inc. subsidiary represents a consumer-centric, profile-based search engine within in a mobile app, designed to assist users in creating efficient and organized, business-to-consumer interaction. PITOOEY! app users create a personalized profile of their favorite businesses and then subscribe to these businesses. This enables the user to receive deals and/or updates on those specific businesses only from businesses of their choice, be it retail store, hotel, entertainment venues, or more.
PITOOEY!’s growth plan is to expand its mobile app technology into strategic geographic markets and key metropolitan areas where it can add relevant data (searchable business databases) in stages, and thus monitor and manage growth.
For more information, visit www.pitooey.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Friday, June 21, 2013
Galectin Therapeutics, Inc. (GALT) Names Jack Callicutt as Chief Financial Officer
Galectin Therapeutics, a leading developer of therapeutics that specifically target galectin proteins in order to treat fibrosis and types of cancer, announced today that Jack W. Callicutt has been recruited to the position of Chief Financial Officer; effective as of July 1, 2013.
Callicutt will oversee Galectin’s financial activities, of which include interaction with capital markets, financial reporting, accounting, risk management, public company governance, as well as public and investor relations. As an active member of the senior management team, Callicutt will play a key position in shaping overall corporate strategy and advising on advance key product assets in the clinic. He will also help insure that financial resources are realized in order to achieve its vision for its pipeline of clinical development assets, a necessity in order to create shareholder value.
“Jack’s demonstrated leadership and deal-making capabilities coupled with his financial management experience and industry knowledge makes him an ideal fit with the needs of the company and further consolidates our leadership group in the Atlanta office. I am looking forward to working closely with Jack and am excited to add an individual of Jack’s caliber to our management team,” stated Dr. Peter G. Traber, Chief Executive Officer and Chief Medical Officer of Galectin Therapeutics Inc. “I also wish to sincerely thank Mr. Thomas McGauley for his years of service to the company, including the last 14 months as acting CFO, and for agreeing to work closely with Jack to assure an orderly transition.”
With over 22 years of public and private company experience, Callicutt holds more than a decade of audit, tax, and SEC registrant experience with a major accounting firm. Most recently he held the position of CFO for REACH Health, Inc., a telemedicine firm, where he successfully implemented a $4 MM private placement. He also previously held positions that include the title of CFO of Vystar Corporation, where he oversaw all areas of financial reporting, accounting, treasury, risk management and administration, as well as secured over $4.5 MM in financing. Furthermore Callicutt acted as CFO for private companies, including IVOX, Tikvah Therapeutics, and Coratus Genetics, a publicly traded biopharmaceutical company. Noting his broad background of experiences spanning a variety of technology intensive industries followed by over a decade-long of holding senior level positions at Deloitte, Callicutt will be a great contribution to the advancement of Galectin.
Callicutt graduated cum laude with a BBA degree in Accounting and Computer science from Delta State University and is a Certified Public Account. Additionally, Callicutt is an active member in community affairs such as the Atlanta Community Food Bank and Habitat for Humanity. He currently resides with his family in Alpharetta, Georgia.
To learn more, visit www.galectintherapeutics.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Callicutt will oversee Galectin’s financial activities, of which include interaction with capital markets, financial reporting, accounting, risk management, public company governance, as well as public and investor relations. As an active member of the senior management team, Callicutt will play a key position in shaping overall corporate strategy and advising on advance key product assets in the clinic. He will also help insure that financial resources are realized in order to achieve its vision for its pipeline of clinical development assets, a necessity in order to create shareholder value.
“Jack’s demonstrated leadership and deal-making capabilities coupled with his financial management experience and industry knowledge makes him an ideal fit with the needs of the company and further consolidates our leadership group in the Atlanta office. I am looking forward to working closely with Jack and am excited to add an individual of Jack’s caliber to our management team,” stated Dr. Peter G. Traber, Chief Executive Officer and Chief Medical Officer of Galectin Therapeutics Inc. “I also wish to sincerely thank Mr. Thomas McGauley for his years of service to the company, including the last 14 months as acting CFO, and for agreeing to work closely with Jack to assure an orderly transition.”
With over 22 years of public and private company experience, Callicutt holds more than a decade of audit, tax, and SEC registrant experience with a major accounting firm. Most recently he held the position of CFO for REACH Health, Inc., a telemedicine firm, where he successfully implemented a $4 MM private placement. He also previously held positions that include the title of CFO of Vystar Corporation, where he oversaw all areas of financial reporting, accounting, treasury, risk management and administration, as well as secured over $4.5 MM in financing. Furthermore Callicutt acted as CFO for private companies, including IVOX, Tikvah Therapeutics, and Coratus Genetics, a publicly traded biopharmaceutical company. Noting his broad background of experiences spanning a variety of technology intensive industries followed by over a decade-long of holding senior level positions at Deloitte, Callicutt will be a great contribution to the advancement of Galectin.
Callicutt graduated cum laude with a BBA degree in Accounting and Computer science from Delta State University and is a Certified Public Account. Additionally, Callicutt is an active member in community affairs such as the Atlanta Community Food Bank and Habitat for Humanity. He currently resides with his family in Alpharetta, Georgia.
To learn more, visit www.galectintherapeutics.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Richard P. Sirny Appointed to Green EnviroTech Holdings Corp. (GETH) Strategic Advisory Board
Yesterday, Green EnviroTech Holdings announced that Richard P. Sirny has been appointed to its newly formed Strategic Advisory Board.
Gary DeLaurentiis, GETH’s CEO, remarked, “We are elated to rapidly expand our world class team. We welcome Richard to our team knowing his input will be invaluable to us.”
Mr. Sirny added, “I am extremely excited about the huge potential of GETH and Petrosonics. Mr. DeLaurentiis and Dr. Mark Cullen are building a team of likeminded dynamic and inventive minds to bring GETH and Petrosonics to the next level and I am honored to be a part of it.”
Mr. Sirny’s career spans over two decades in the Middle East, primarily in the industrial, commercial and residential project development, project management, contracts, and financing capacities. From 2010 to present, Mr. Sirny has developed several energy and oil and gas project proposals and contract agreements on projects with valuations of $100million to $4 billion.
Between 2005 and 2009, Mr. Sirny worked for the Saudi Arabia Ministry of Oil and Minerals in the infrastructure and phosphate fertilizer plant development for Ras Al Khair Industrial City. He was the Program Director for Worley Parsons, which included the handling of all agency interface and the associated agreements and contracts. Mr. Sirny also worked for the Kingdom of Saudi Arabia from 2000 to 2005 in project development consulting and project management for SIPCHEM, SABIC, ARAMCO, and more.
He holds a PhD in International Finance, concurrent with an MBA as well as a BSME/BSCE double Major in Mechanics and Chemical. He has extensive special training in integrated mechanical inspection and welding inspection (including X-Ray, Contract Law, Business Law, Installation and Maintenance of Inert Gas Systems, and Computerized “Project” Scheduling and Planning).
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Gary DeLaurentiis, GETH’s CEO, remarked, “We are elated to rapidly expand our world class team. We welcome Richard to our team knowing his input will be invaluable to us.”
Mr. Sirny added, “I am extremely excited about the huge potential of GETH and Petrosonics. Mr. DeLaurentiis and Dr. Mark Cullen are building a team of likeminded dynamic and inventive minds to bring GETH and Petrosonics to the next level and I am honored to be a part of it.”
Mr. Sirny’s career spans over two decades in the Middle East, primarily in the industrial, commercial and residential project development, project management, contracts, and financing capacities. From 2010 to present, Mr. Sirny has developed several energy and oil and gas project proposals and contract agreements on projects with valuations of $100million to $4 billion.
Between 2005 and 2009, Mr. Sirny worked for the Saudi Arabia Ministry of Oil and Minerals in the infrastructure and phosphate fertilizer plant development for Ras Al Khair Industrial City. He was the Program Director for Worley Parsons, which included the handling of all agency interface and the associated agreements and contracts. Mr. Sirny also worked for the Kingdom of Saudi Arabia from 2000 to 2005 in project development consulting and project management for SIPCHEM, SABIC, ARAMCO, and more.
He holds a PhD in International Finance, concurrent with an MBA as well as a BSME/BSCE double Major in Mechanics and Chemical. He has extensive special training in integrated mechanical inspection and welding inspection (including X-Ray, Contract Law, Business Law, Installation and Maintenance of Inert Gas Systems, and Computerized “Project” Scheduling and Planning).
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Capstone Turbine Corp. (CPST) Receives First Order for Two C200s from Regional Hospital in Slovenia
Capstone Turbine, the world’s leading clean technology manufacturer of microturbine energy systems, today announced that Capstone Micro Turbines in Slovenia has received its first order for two C200s to be installed at Splošna bolnišnica Novo Mesto, the general hospital in Novo Mesto, Slovenia.
Liabach, Capstone’s distributor for Croatia and Slovenia, secured the order and will commission the units this fall.
With plans to be installed on the hospital’s rooftop, the C200s will operate in a combined cooling, heating, and power (CCHP) application in order to lower emissions, increase energy efficiency, and ensure reliable power generation for the 377-bed regional hospital. Fueled by natural gas, the microturbines will be grid-connected and provide electricity, heating, and hot domestic water for the facility.
Funded in part by the Council of the European Union, the project will help the hospital meet international efficiency standards. The EU is hoping to attain a 20 percent cut in Europe’s annual primary energy consumption by 2020. Hospital officials anticipate natural gas efficiencies to increase from 34 percent to 73 percent following installation of the C200s.
“The microturbines’ ultra-low greenhouse gas and noise emissions, low vibration, and low maintenance costs, paired with their ability to withstand Slovenia’s harsh climate, make them the best technology for the hospital,” commented Jim Crouse, Capstone’s Executive Vice President of Sales and Marketing. The C200 will feature Capstone’s patented oil-free air bearing technology, providing both remote monitoring and diagnostic capabilities, and integrated utility synchronization and protection. The small, modular systems are designed to allow easy and low-cost installation.
“Worldwide interest in Capstone’s C200 product continues to grow,” stated Darren Jamison, Capstone’s President and Chief Executive Officer. “This order not only introduces Capstone into yet another new marketplace, but also exemplifies Capstone’s global appeal and diversity. Our value proposition of high reliability, long maintenance intervals, and low total cost of ownership provides an unrivaled product that makes sound business sense for countless applications.”
For more information on Capstone Turbine, visit www.capstoneturbine.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Liabach, Capstone’s distributor for Croatia and Slovenia, secured the order and will commission the units this fall.
With plans to be installed on the hospital’s rooftop, the C200s will operate in a combined cooling, heating, and power (CCHP) application in order to lower emissions, increase energy efficiency, and ensure reliable power generation for the 377-bed regional hospital. Fueled by natural gas, the microturbines will be grid-connected and provide electricity, heating, and hot domestic water for the facility.
Funded in part by the Council of the European Union, the project will help the hospital meet international efficiency standards. The EU is hoping to attain a 20 percent cut in Europe’s annual primary energy consumption by 2020. Hospital officials anticipate natural gas efficiencies to increase from 34 percent to 73 percent following installation of the C200s.
“The microturbines’ ultra-low greenhouse gas and noise emissions, low vibration, and low maintenance costs, paired with their ability to withstand Slovenia’s harsh climate, make them the best technology for the hospital,” commented Jim Crouse, Capstone’s Executive Vice President of Sales and Marketing. The C200 will feature Capstone’s patented oil-free air bearing technology, providing both remote monitoring and diagnostic capabilities, and integrated utility synchronization and protection. The small, modular systems are designed to allow easy and low-cost installation.
“Worldwide interest in Capstone’s C200 product continues to grow,” stated Darren Jamison, Capstone’s President and Chief Executive Officer. “This order not only introduces Capstone into yet another new marketplace, but also exemplifies Capstone’s global appeal and diversity. Our value proposition of high reliability, long maintenance intervals, and low total cost of ownership provides an unrivaled product that makes sound business sense for countless applications.”
For more information on Capstone Turbine, visit www.capstoneturbine.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Zhone Technologies Inc. (ZHNE) Video Chart for Friday, June 21, 2013
ZHNE climbed on Thursday, bucking the trend as the broad markets sold off. The chart is forming a pennant pattern and the pps is trying to come off the bottom of the pattern as the indicators lean towards bullishness.
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
To view the video chart, visit the following link: http://www.missionir.com/videos.html
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Thursday, June 20, 2013
Digital Cinema Destinations Corp. (DCIN) Puts Alternative, Revenue-Generating Twist on Cinematic Offering
U.S. motion picture exhibitor Digital Cinema Destinations, operating under the Digiplex Destinations brand, has found a honey hole in the movie theater industry through the integration of alternative programming.
In addition to major motion pictures, DCIN theaters show live sporting events, concerts, conferences, operas, ballet, Broadway plays, and other programming such as Indie features and documentaries.
The company’s strategy is to offer a wide range of alternative programming and build awareness and attendance gains by executing active targeted marketing and comprehensive social media outreach.
DCIN has found that alternative programming consistently outperforms the lowest, and often highest, grossing movies at higher prices.
As a percentage of total third quarter 2013 admission revenues, alternative programming averaged roughly 6 percent at eight locations (comprised of 73 screens) owned for more than one year.
The company’s long-term goal is to generate 20 percent of its total box receipts from alternative content, improving attendance metrics with a roughly 50 percent higher ticket price and by replacing underperforming Hollywood titles with alternative programming.
In addition to alternative programming, select DCIN theater locations have started presenting special engagements of major Hollywood movie releases with both Spanish and English sound tracks. The company plans to further expand this entertainment option to include more locations and to feature Asian and other foreign language presentations.
DCIN has also formed a specialty content joint venture with Nehst Studios through which it features a curated series of documentaries and indie features that have been hand-selected from world’s leading film festivals. DCIN receives 50 percent of all net downstream/ancillary revenues stemming from this joint venture, including DVD, digital downloads, and international broadcast rights.
For more information, visit www.digitalcinemadestinations.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
In addition to major motion pictures, DCIN theaters show live sporting events, concerts, conferences, operas, ballet, Broadway plays, and other programming such as Indie features and documentaries.
The company’s strategy is to offer a wide range of alternative programming and build awareness and attendance gains by executing active targeted marketing and comprehensive social media outreach.
DCIN has found that alternative programming consistently outperforms the lowest, and often highest, grossing movies at higher prices.
As a percentage of total third quarter 2013 admission revenues, alternative programming averaged roughly 6 percent at eight locations (comprised of 73 screens) owned for more than one year.
The company’s long-term goal is to generate 20 percent of its total box receipts from alternative content, improving attendance metrics with a roughly 50 percent higher ticket price and by replacing underperforming Hollywood titles with alternative programming.
In addition to alternative programming, select DCIN theater locations have started presenting special engagements of major Hollywood movie releases with both Spanish and English sound tracks. The company plans to further expand this entertainment option to include more locations and to feature Asian and other foreign language presentations.
DCIN has also formed a specialty content joint venture with Nehst Studios through which it features a curated series of documentaries and indie features that have been hand-selected from world’s leading film festivals. DCIN receives 50 percent of all net downstream/ancillary revenues stemming from this joint venture, including DVD, digital downloads, and international broadcast rights.
For more information, visit www.digitalcinemadestinations.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Dynavax Technologies Corp. (DVAX) Chief Scientific Officer Dr. Tim R. Mossman Receives Novartis Prize for Basic Immunology
Clinical-stage biopharmaceutical company Dynavax Technologies has announced that Dr. Robert L. Coffman, the company’s chief scientific officer, and his former collaborator, Dr. Tim R. Mossman, have been awarded the 2013 Novartis Prize for Basic Immunology for their pioneering research defining subsets of immune system T cells that have advanced the understanding of infectious, autoimmune, and allergic diseases.
In the 1980s, while working collaboratively at DNAX Research Institute in Palo Alto, Calif., Coffman and Mossman determined the distinct functions of two T-helper cell subsets: Th1 cells, which play a significant role in cellular immunity that is critical for resistance to infections; and Th2 cells, which can induce allergic diseases. The two doctors also discovered that dysregulation of Th1 and Th2 cell functions was implicated in various immunological diseases.
The fundamental discovery made by Mossman and Coffman, regarding the specific types of T cells that helped either cellular or humoral (antibody-mediated) immunity, changed the way the immune system’s workings are understood and also led to major advances in the design of therapies for infectious, inflammatory and allergic diseases, as well as in vaccine design.
The award ceremony for the Novartis Prize will take place on Aug. 23 at the 15th International Congress of Immunology, held in Milan, Italy. The Novartis Prizes for Immunology, established in 1990, are awarded every three years for groundbreaking contributions to the fields of basic and clinical immunology, as judged by an independent panel of experts.
For more information about Dynavax, visit www.dynavax.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
In the 1980s, while working collaboratively at DNAX Research Institute in Palo Alto, Calif., Coffman and Mossman determined the distinct functions of two T-helper cell subsets: Th1 cells, which play a significant role in cellular immunity that is critical for resistance to infections; and Th2 cells, which can induce allergic diseases. The two doctors also discovered that dysregulation of Th1 and Th2 cell functions was implicated in various immunological diseases.
The fundamental discovery made by Mossman and Coffman, regarding the specific types of T cells that helped either cellular or humoral (antibody-mediated) immunity, changed the way the immune system’s workings are understood and also led to major advances in the design of therapies for infectious, inflammatory and allergic diseases, as well as in vaccine design.
The award ceremony for the Novartis Prize will take place on Aug. 23 at the 15th International Congress of Immunology, held in Milan, Italy. The Novartis Prizes for Immunology, established in 1990, are awarded every three years for groundbreaking contributions to the fields of basic and clinical immunology, as judged by an independent panel of experts.
For more information about Dynavax, visit www.dynavax.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Quantum Fuel Systems (QTWW) Completes Development of Alternative Fuel Engine for Mahindra and Mahindra
Quantum Fuel Systems Technologies Worldwide, a prominent player in the natural gas, alternative fuel systems, and clean propulsion vehicle technology markets, announced today that it has successfully completed development of a turbocharged, inter-cooled, and electronically fuel injected gaseous fuel engine for the leading Indian vehicle manufacturer and industrial conglomerate, Mahindra and Mahindra. Quantum reengineered the base engine, supplied by Mahindra and Mahindra, to incorporate gaseous fuel metering systems and state-of-the-art engine controls that enable the engine to run on gaseous hydrogen, similar to a natural gas engine.
Mahindra Group contracted Quantum to spearhead the development and calibration of a gaseous fuel engine that performed to a set of aggressive performance and emissions standards. Quantum provided its gaseous fuel injectors and integrated low and high pressure regulators, fuel rail, fuel sensors, and advanced engine controller for use in the project. In addition, Quantum created the engine control software strategies and performed engine calibration. Moving forward, the engine will undergo fine tuning by Mahindra in India, then will be used in vehicle level evaluations and demonstrations.
“The program with Mahindra and Mahindra further demonstrates Quantum’s broad engineering capabilities in developing advanced gaseous fuel systems and engines,” said Brian Olson, President and CEO of Quantum. “This program has leveraged Quantum’s two decades of experience in compressed natural gas engines and fully-integrated fuel systems, and working with leading global automakers.”
Quantum combines nearly 20 years of lightweight fuel storage and system integration experience with strong expertise in materials, system integration, vehicle control software, emission and durability testing, validation, and manufacturing capabilities. Quantum has designed developed and validated natural gas (CNG), bi-fuel (gasoline/CNG), propane (LPG), and hydrogen fuel systems and vehicles since 1997, during which time thousands of systems were produced and sold, with Quantum listed as the manufacturer of record by California Air Resource Board (CARB).
For further information, please visit www.qtww.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Mahindra Group contracted Quantum to spearhead the development and calibration of a gaseous fuel engine that performed to a set of aggressive performance and emissions standards. Quantum provided its gaseous fuel injectors and integrated low and high pressure regulators, fuel rail, fuel sensors, and advanced engine controller for use in the project. In addition, Quantum created the engine control software strategies and performed engine calibration. Moving forward, the engine will undergo fine tuning by Mahindra in India, then will be used in vehicle level evaluations and demonstrations.
“The program with Mahindra and Mahindra further demonstrates Quantum’s broad engineering capabilities in developing advanced gaseous fuel systems and engines,” said Brian Olson, President and CEO of Quantum. “This program has leveraged Quantum’s two decades of experience in compressed natural gas engines and fully-integrated fuel systems, and working with leading global automakers.”
Quantum combines nearly 20 years of lightweight fuel storage and system integration experience with strong expertise in materials, system integration, vehicle control software, emission and durability testing, validation, and manufacturing capabilities. Quantum has designed developed and validated natural gas (CNG), bi-fuel (gasoline/CNG), propane (LPG), and hydrogen fuel systems and vehicles since 1997, during which time thousands of systems were produced and sold, with Quantum listed as the manufacturer of record by California Air Resource Board (CARB).
For further information, please visit www.qtww.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Neonode, Inc. (NEON) Lands Design Win with Premier Global OEM of Home Appliances Following Launch of New Multisensing HOME Platform
Neonode, the optical touch technology company, today announced that the company has acquired winning design with a premier global home appliance OEM. The win comes at a crucial time for Neonode, coinciding with the launch of its new home appliance touch control platform, Multisensing HOME, which targets next-generation major and small home appliances.
“We are experiencing increased attention from appliance OEM’s, looking to license and implement our Multisensing solutions, which offer a compelling mix of high-performance, power efficiency, and attractive cost,” stated Thomas Eriksson, CEO of Neonode.
Designed for easy-integration into domestic appliances, the Multisensing HOME platform works with washing machines, dishwashers, stoves, fridge-freezers, microwaves, and more. Specifically, the platform enables the appliance OEM’s to replace antiquated button, dials, and resistive touchpads, through the integration of high-performance proximity sensing (touchless) and multi-touch controls. Additionally, this also simplifies OEM production processes while shortening time to market and reducing the bill of materials (BOM).
Utilizing Neonode’s cutting-edge technologies, this platform provides a wide array of Multisensing features, including:
• Real-time touch that integrates proximity-sensing and unlimited gestures
• Tolerance of extreme temperature, vibration, and electromagnetic (EMC) ranges
• Market-leading power efficiency; under 1 mW
• Optically clear and glare-free user-interfaces, which are water resistant
• Product customization helps OEMs differentiate and shorten development cycles
• Solid-state touch control, reducing production and warranty costs
“Our new home appliance touch platform addresses all the critical requirements for sturdiness, ultra-low power consumption, and resistance to electrical interference, vibration, and water sprays. It also facilitates elegant industrial design, thereby improving product aesthetics and usability,” added Thomas Eriksson.
The global market for major electric household appliances is expected to reach 543 million units by 2015, with the small appliance market eclipsing 616M units, according to a report by Global Industry Analytics, Inc.
For more information on Neonode, visit www.neonode.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
“We are experiencing increased attention from appliance OEM’s, looking to license and implement our Multisensing solutions, which offer a compelling mix of high-performance, power efficiency, and attractive cost,” stated Thomas Eriksson, CEO of Neonode.
Designed for easy-integration into domestic appliances, the Multisensing HOME platform works with washing machines, dishwashers, stoves, fridge-freezers, microwaves, and more. Specifically, the platform enables the appliance OEM’s to replace antiquated button, dials, and resistive touchpads, through the integration of high-performance proximity sensing (touchless) and multi-touch controls. Additionally, this also simplifies OEM production processes while shortening time to market and reducing the bill of materials (BOM).
Utilizing Neonode’s cutting-edge technologies, this platform provides a wide array of Multisensing features, including:
• Real-time touch that integrates proximity-sensing and unlimited gestures
• Tolerance of extreme temperature, vibration, and electromagnetic (EMC) ranges
• Market-leading power efficiency; under 1 mW
• Optically clear and glare-free user-interfaces, which are water resistant
• Product customization helps OEMs differentiate and shorten development cycles
• Solid-state touch control, reducing production and warranty costs
“Our new home appliance touch platform addresses all the critical requirements for sturdiness, ultra-low power consumption, and resistance to electrical interference, vibration, and water sprays. It also facilitates elegant industrial design, thereby improving product aesthetics and usability,” added Thomas Eriksson.
The global market for major electric household appliances is expected to reach 543 million units by 2015, with the small appliance market eclipsing 616M units, according to a report by Global Industry Analytics, Inc.
For more information on Neonode, visit www.neonode.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Atossa Genetics, Inc. (ATOS) Inks Agreement with Fisher HealthCare to Distribute ‘the Pap Smear for Breast Cancer’
Atossa Genetics announced it has signed an agreement with Fisher HealthCare, Inc. (part of Thermo Fisher Scientific) to distribute ForeCYTE Breast Health devices.
Atossa’s ForeCYTE Breast Health device consists of the patented MASCT pump and ForeCYTE patient collection kits. Physicians and nurses utilize the MASCT system to collect small amounts of nipple aspirate fluid for cytological and genomic analysis, which is conducted at Atossa’s wholly owned National Reference Laboratory for Breast Health.
The ForeCYTE test, touted as “the Pap smear for breast cancer,” is a noninvasive procedure that is both painless and fast. Performed in a physician’s office, the test provides crucial early detection of precancerous conditions, which can progress to cancer over a period of approximately eight years before mammography or other means can detect it. The test is intended for the around 110 million women in the United States who are between the ages 18-73, including younger women and women with dense breasts, breast implants, or BRCA gene mutations.
It is Atossa Genetics’ goal, through the ForeCYTE test, to reduce the unyieldingly high rates of breast cancer through early detection and treatment of precursor changes leading to the disease, just as the Pap smear has led to a more than 70 percent reduction in cervical cancer rates. Through the company’s partnership with Fisher HealthCare, the test will be made available to women throughout the U.S.
“Fisher HealthCare is a recognized leader in providing diagnostic solutions to customers in the acute care, physician office and reference lab markets, and we are excited to have entered into this distribution agreement,” said Atossa Genetics Chairman, CEO and President Dr. Steven Quay. “We believe our ForeCYTE test represents a significant breakthrough in breast cancer risk assessment, and we look forward to working with our partners to make the ForeCYTE test a standard of care.”
For more information about the ForeCYTE Breast Health Risk Assessment Test, visit www.atossagenetics.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Atossa’s ForeCYTE Breast Health device consists of the patented MASCT pump and ForeCYTE patient collection kits. Physicians and nurses utilize the MASCT system to collect small amounts of nipple aspirate fluid for cytological and genomic analysis, which is conducted at Atossa’s wholly owned National Reference Laboratory for Breast Health.
The ForeCYTE test, touted as “the Pap smear for breast cancer,” is a noninvasive procedure that is both painless and fast. Performed in a physician’s office, the test provides crucial early detection of precancerous conditions, which can progress to cancer over a period of approximately eight years before mammography or other means can detect it. The test is intended for the around 110 million women in the United States who are between the ages 18-73, including younger women and women with dense breasts, breast implants, or BRCA gene mutations.
It is Atossa Genetics’ goal, through the ForeCYTE test, to reduce the unyieldingly high rates of breast cancer through early detection and treatment of precursor changes leading to the disease, just as the Pap smear has led to a more than 70 percent reduction in cervical cancer rates. Through the company’s partnership with Fisher HealthCare, the test will be made available to women throughout the U.S.
“Fisher HealthCare is a recognized leader in providing diagnostic solutions to customers in the acute care, physician office and reference lab markets, and we are excited to have entered into this distribution agreement,” said Atossa Genetics Chairman, CEO and President Dr. Steven Quay. “We believe our ForeCYTE test represents a significant breakthrough in breast cancer risk assessment, and we look forward to working with our partners to make the ForeCYTE test a standard of care.”
For more information about the ForeCYTE Breast Health Risk Assessment Test, visit www.atossagenetics.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Plug Power, Inc. (PLUG) Adds CEO of Air Liquide to Board of Directors
Plug Power, a leader in providing clean and reliable energy solutions, has a new addition to its board of directors, Eric Prades, CEO of Air Liquide Advanced Business.
With more than 20 years of international strategic and operations leadership at Air Liquide, Prades is well versed in Hydrogen Energy markets. As of 2008, the company has developed into a prominent leader within the European hydrogen industry, having distributed hundreds of hydrogen fuel-cell systems.
In addition, Prades oversees the ambitious Horizon Hydrogen Energy (H2E) program, a 200 million Euro research and development program. With different completion targets dispersed throughout 2009 to 2016, the program currently works to build sustainable and competitive hydrogen-energy solutions in France. The program, led by Air Liquide, involves 19 other French companies and is being funded by Oseo, a French agency known for innovation.
Prior to joining Air Liquide, Prades worked for the Thomson Group, where he cultivated extensive operations experience in Europe and Asia through a variety of positions, ending as the General Manager of Operations for Thailand.
Prades is joining the Plug Power board as a part of a strategic $6.5 million investment that will help fuel strategic growth in its hydrogen fuel cell business for horizontal markets. Plug Power’s flagship GenDrive fuel cells have been successfully deployed to customer sites such as Walmart, Sysco, P&G, BMW, and the recently announced Ace Hardware Corp.
“Eric’s deep understanding of the technology and business dynamics of the hydrogen fuel cell market makes him a perfect candidate for our board of directors,” stated Andy Marsh, President and CEO of Plug Power. “I am pleased to welcome Eric to our board and I look forward to working with him as we grow Plug Power.”
To learn more, visit www.plugpower.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
With more than 20 years of international strategic and operations leadership at Air Liquide, Prades is well versed in Hydrogen Energy markets. As of 2008, the company has developed into a prominent leader within the European hydrogen industry, having distributed hundreds of hydrogen fuel-cell systems.
In addition, Prades oversees the ambitious Horizon Hydrogen Energy (H2E) program, a 200 million Euro research and development program. With different completion targets dispersed throughout 2009 to 2016, the program currently works to build sustainable and competitive hydrogen-energy solutions in France. The program, led by Air Liquide, involves 19 other French companies and is being funded by Oseo, a French agency known for innovation.
Prior to joining Air Liquide, Prades worked for the Thomson Group, where he cultivated extensive operations experience in Europe and Asia through a variety of positions, ending as the General Manager of Operations for Thailand.
Prades is joining the Plug Power board as a part of a strategic $6.5 million investment that will help fuel strategic growth in its hydrogen fuel cell business for horizontal markets. Plug Power’s flagship GenDrive fuel cells have been successfully deployed to customer sites such as Walmart, Sysco, P&G, BMW, and the recently announced Ace Hardware Corp.
“Eric’s deep understanding of the technology and business dynamics of the hydrogen fuel cell market makes him a perfect candidate for our board of directors,” stated Andy Marsh, President and CEO of Plug Power. “I am pleased to welcome Eric to our board and I look forward to working with him as we grow Plug Power.”
To learn more, visit www.plugpower.com
About MissionIR
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website
http://www.missionir.com/disclaimer.html
Subscribe to:
Posts (Atom)